EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document L:2022:190:FULL
Official Journal of the European Union, L 190, 19 July 2022
Official Journal of the European Union, L 190, 19 July 2022
Official Journal of the European Union, L 190, 19 July 2022
ISSN 1977-0677 |
||
Official Journal of the European Union |
L 190 |
|
![]() |
||
English edition |
Legislation |
Volume 65 |
|
|
Corrigenda |
|
|
* |
|
|
|
(1) Text with EEA relevance. |
EN |
Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period. The titles of all other Acts are printed in bold type and preceded by an asterisk. |
II Non-legislative acts
REGULATIONS
19.7.2022 |
EN |
Official Journal of the European Union |
L 190/1 |
COUNCIL IMPLEMENTING REGULATION (EU) 2022/1230
of 18 July 2022
implementing Article 2(3) of Regulation (EC) No 2580/2001 on specific restrictive measures directed against certain persons and entities with a view to combating terrorism, and repealing Implementing Regulation (EU) 2022/147
THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Council Regulation (EC) No 2580/2001 of 27 December 2001 on specific restrictive measures directed against certain persons and entities with a view to combating terrorism (1), and in particular Article 2(3) thereof,
Having regard to the proposal from the High Representative of the Union for Foreign Affairs and Security Policy,
Whereas:
(1) |
On 3 February 2022, the Council adopted Implementing Regulation (EU) 2022/147 (2), implementing Article 2(3) of Regulation (EC) No 2580/2001 and establishing an updated list of persons, groups and entities to which Regulation (EC) No 2580/2001 applies (‘the list’). |
(2) |
The Council has provided, where practically possible, all the persons, groups and entities with statements of reasons explaining why they were entered into the list. |
(3) |
By way of a notice published in the Official Journal of the European Union, the Council informed the persons, groups and entities on the list that it had decided to keep them thereon. The Council also informed those persons, groups and entities concerned that it was possible to request a statement of the Council’s reasons for entering them into the list where such a statement had not already been communicated to them. |
(4) |
The Council has reviewed the list as required by Article 2(3) of Regulation (EC) No 2580/2001. When carrying out that review, the Council took into account the observations submitted to it by those concerned as well as the updated information received from the competent national authorities on the status of listed individuals and entities at the national level. |
(5) |
The Council has verified that competent authorities, as referred to in Article 1(4) of Council Common Position 2001/931/CFSP (3), have taken decisions with regard to all persons, groups and entities on the list to the effect that they have been involved in terrorist acts within the meaning of Article 1(2) and (3) of Common Position 2001/931/CFSP. The Council has also concluded that the persons, groups and entities to which Articles 2, 3 and 4 of Common Position 2001/931/CFSP apply should continue to be subject to the specific restrictive measures provided for in Regulation (EC) No 2580/2001. |
(6) |
The list should be updated accordingly and Implementing Regulation (EU) 2022/147 should be repealed, |
HAS ADOPTED THIS REGULATION:
Article 1
The list provided for in Article 2(3) of Regulation (EC) No 2580/2001 is set out in the Annex to this Regulation.
Article 2
Implementing Regulation (EU) 2022/147 is hereby repealed.
Article 3
This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 18 July 2022.
For the Council
The President
J. BORRELL FONTELLES
(1) OJ L 344, 28.12.2001, p. 70.
(2) Council Implementing Regulation (EU) 2022/147 of 3 February 2022 implementing Article 2(3) of Regulation (EC) No 2580/2001 on specific restrictive measures directed against certain persons and entities with a view to combating terrorism, and repealing Implementing Regulation (EU) 2021/1188 (OJ L 25, 4.2.2022, p. 1).
(3) Council Common Position 2001/931/CFSP of 27 December 2001 on the application of specific measures to combat terrorism (OJ L 344, 28.12.2001, p. 93).
ANNEX
LIST OF PERSONS, GROUPS AND ENTITIES REFERRED TO IN ARTICLE 1
I. PERSONS
1. |
ABDOLLAHI Hamed (a.k.a. Mustafa Abdullahi), born 11.8.1960 in Iran. Passport number: D9004878. |
2. |
AL-NASSER Abdelkarim Hussein Mohamed, born in Al Ihsa (Saudi Arabia), citizen of Saudi Arabia. |
3. |
AL-YACOUB Ibrahim Salih Mohammed, born 16.10.1966 in Tarut (Saudi Arabia), citizen of Saudi Arabia. |
4. |
ARBABSIAR Manssor (a.k.a. Mansour Arbabsiar), born 6.3.1955 or 15.3.1955 in Iran. Iranian and US national, Passport number: C2002515 (Iran); Passport number: 477845448 (USA). National ID number: 07442833, expiry date 15.3.2016 (USA driving licence). |
5. |
ASSADI Assadollah (a.k.a. Assadollah Asadi), born 22.12.1971 in Teheran (Iran), Iranian national. Iranian diplomatic passport number: D9016657. |
6. |
BOUYERI Mohammed (a.k.a. Abu Zubair, a.k.a. Sobiar, a.k.a. Abu Zoubair), born 8.3.1978 in Amsterdam (The Netherlands). |
7. |
EL HAJJ Hassan Hassan, born 22.3.1988 in Zaghdraiya, Sidon, Lebanon, Canadian citizen. Passport number: JX446643 (Canada). |
8. |
HASHEMI MOGHADAM Saeid, born 6.8.1962 in Teheran (Iran), Iranian national. Passport number: D9016290, valid until 4.2.2019. |
9. |
AL-DIN Izz Hasan (a.k.a. Garbaya Ahmed, a.k.a. Sa’id, a.k.a. Salwwan Samir), Lebanon, born 1963 in Lebanon, citizen of Lebanon. |
10. |
MELIAD Farah, born 5.11.1980 in Sydney (Australia), Australian citizen. Passport number: M2719127 (Australia). |
11. |
MOHAMMED Khalid Sheikh (a.k.a. Ali Salem, a.k.a. Bin Khalid Fahd Bin Abdallah, a.k.a. Henin Ashraf Refaat Nabith, a.k.a. Wadood Khalid Abdul), born 14.4.1965 or 1.3.1964 in Pakistan, passport number 488555. |
12. |
SHAHLAI Abdul Reza (a.k.a. Abdol Reza Shala’i, a.k.a. Abd-al Reza Shalai, a.k.a. Abdorreza Shahlai, a.k.a. Abdolreza Shahla’i, a.k.a. Abdul-Reza Shahlaee, a.k.a. Hajj Yusef, a.k.a. Haji Yusif, a.k.a. Hajji Yasir, a.k.a. Hajji Yusif, a.k.a. Yusuf Abu-al-Karkh), born circa 1957 in Iran. Addresses: (1) Kermanshah, Iran, (2) Mehran Military Base, Ilam Province, Iran. |
13. |
SHAKURI Ali Gholam, born circa 1965 in Tehran, Iran. |
II. GROUPS AND ENTITIES
1. |
‘Abu Nidal Organisation’ – ‘ANO’ (a.k.a. ‘Fatah Revolutionary Council’, a.k.a. ‘Arab Revolutionary Brigades’, a.k.a. ‘Black September’, a.k.a. ‘Revolutionary Organisation of Socialist Muslims’). |
2. |
‘Al-Aqsa Martyrs’ Brigade’. |
3. |
‘Al-Aqsa e.V.’. |
4. |
‘Babbar Khalsa’. |
5. |
‘Communist Party of the Philippines’, including ‘New People’s Army’ – ‘NPA’, Philippines. |
6. |
Directorate for Internal Security of the Iranian Ministry for Intelligence and Security. |
7. |
‘Gama’a al-Islamiyya’ (a.k.a. ‘Al-Gama’a al-Islamiyya’) (‘Islamic Group’ – ‘IG’). |
8. |
‘İslami Büyük Doğu Akıncılar Cephesi’ – ‘IBDA-C’ (‘Great Islamic Eastern Warriors Front’). |
9. |
‘Hamas’, including ‘Hamas-Izz al-Din al-Qassem’. |
10. |
‘Hizballah Military Wing’ (a.k.a. ‘Hezbollah Military Wing’, a.k.a. ‘Hizbullah Military Wing’, a.k.a. ‘Hizbollah Military Wing’, a.k.a. ‘Hezballah Military Wing’, a.k.a. ‘Hisbollah Military Wing’, a.k.a. ‘Hizbu’llah Military Wing’ a.k.a. ‘Hizb Allah Military Wing’, a.k.a. ‘Jihad Council’ (and all units reporting to it, including the External Security Organisation)). |
11. |
‘Hizbul Mujahideen’ – ‘HM’. |
12. |
‘Khalistan Zindabad Force’ – ‘KZF’. |
13. |
‘Kurdistan Workers’ Party’ – ‘PKK’ (a.k.a. ‘KADEK’, a.k.a. ‘KONGRA-GEL’). |
14. |
‘Liberation Tigers of Tamil Eelam’ – ‘LTTE’. |
15. |
‘Ejército de Liberación Nacional’ (‘National Liberation Army’). |
16. |
‘Palestinian Islamic Jihad’ – ‘PIJ’. |
17. |
‘Popular Front for the Liberation of Palestine’ – ‘PFLP’. |
18. |
‘Popular Front for the Liberation of Palestine – General Command’ (a.k.a. ‘PFLP – General Command’). |
19. |
‘Devrimci Halk Kurtuluș Partisi-Cephesi’ – ‘DHKP/C’ (a.k.a. ‘Devrimci Sol’ (‘Revolutionary Left’), a.k.a. ‘Dev Sol’) (‘Revolutionary People’s Liberation Army/Front/Party’). |
20. |
‘Sendero Luminoso’ – ‘SL’ (‘Shining Path’). |
21. |
‘Teyrbazen Azadiya Kurdistan’ – ‘TAK’ (a.k.a. ‘Kurdistan Freedom Falcons’, a.k.a. ‘Kurdistan Freedom Hawks’). |
19.7.2022 |
EN |
Official Journal of the European Union |
L 190/5 |
COUNCIL IMPLEMENTING REGULATION (EU) 2022/1231
of 18 July 2022
implementing Regulation (EC) No 765/2006 concerning restrictive measures in view of the situation in Belarus and the involvement of Belarus in the Russian aggression against Ukraine
THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Council Regulation (EC) No 765/2006 of 18 May 2006 concerning restrictive measures in view of the situation in Belarus and the involvement of Belarus in the Russian aggression against Ukraine (1), and in particular Article 8a(3) thereof,
Having regard to the proposal from the High Representative of the Union for Foreign Affairs and Security Policy,
Whereas:
(1) |
On 18 May 2006, the Council adopted Regulation (EC) No 765/2006. |
(2) |
Further to an evaluation of the relevant circumstances, one entry should be deleted from the list of natural and legal persons, entities and bodies set out in Annex I to Regulation (EC) No 765/2006. |
(3) |
Regulation (EC) No 765/2006 should therefore be amended accordingly, |
HAS ADOPTED THIS REGULATION:
Article 1
Annex I to Regulation (EC) No 765/2006 is amended in accordance with the Annex to this Regulation.
Article 2
This Regulation shall enter into force on the date following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 18 July 2022.
For the Council
The President
J. BORRELL FONTELLES
ANNEX
The following entry is deleted from the list set out in Section B (‘Legal persons, entities and bodies referred to in Article 2(1)’) of Annex I to Regulation (EC) No 765/2006:
‘23. |
Cham Wings Airlines’. |
19.7.2022 |
EN |
Official Journal of the European Union |
L 190/7 |
COMMISSION IMPLEMENTING REGULATION (EU) 2022/1232
of 13 July 2022
granting a Union authorisation for the biocidal product family ‘INTEROX Biocidal Product Family 1’
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (1), and in particular the Article 44(5), first subparagraph, thereof,
Whereas:
(1) |
On 25 January 2017, Solvay Chemicals International S.A. submitted an application, in accordance with Article 43(1) of Regulation (EU) No 528/2012, for authorisation of a biocidal product family named ‘INTEROX Biocidal Product Family 1’ of product-types 2, 3 and 4, as described in Annex V to that Regulation, providing written confirmation that the competent authority of Finland had agreed to evaluate the application. The application was recorded under case number BC-WX029254-02 in the Register for Biocidal Products. |
(2) |
‘INTEROX Biocidal Product Family 1’ contains hydrogen peroxide as the active substance, which is included in the Union list of approved active substance referred to in Article 9(2) of Regulation (EU) No 528/2012 for product-types 2, 3 and 4. |
(3) |
On 21 April 2021, the evaluating competent authority submitted, in accordance with Article 44(1) of Regulation (EU) No 528/2012, an assessment report and the conclusions of its evaluation to the European Chemicals Agency (‘the Agency’). |
(4) |
On 4 November 2021, the Agency submitted to the Commission an opinion (2), including the draft summary of the biocidal product characteristics (‘SPC’) of ‘INTEROX Biocidal Product Family 1’ and the final assessment report on the biocidal product family in accordance with Article 44(3) of Regulation (EU) No 528/2012. |
(5) |
The opinion concludes that ‘INTEROX Biocidal Product Family 1’ is a ‘biocidal product family’ within the meaning of Article 3(1), point (s), of Regulation (EU) No 528/2012, that it is eligible for Union authorisation in accordance with Article 42(1) of that Regulation and that subject to compliance with the draft SPC, it meets the conditions laid down in Article 19(1) and (6) of that Regulation. |
(6) |
On 16 November 2021, the Agency transmitted to the Commission the draft SPC in all the official languages of the Union in accordance with Article 44(4) of Regulation (EU) No 528/2012. |
(7) |
The Commission concurs with the opinion of the Agency and considers it therefore appropriate to grant a Union authorisation for ‘INTEROX Biocidal Product Family 1’. |
(8) |
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on biocidal products, |
HAS ADOPTED THIS REGULATION:
Article 1
A Union authorisation with authorisation number EU-0027468-0000 is granted to Solvay Chemicals International S.A. for the making available on the market and use of the biocidal product family ‘INTEROX Biocidal Product Family 1’ in accordance with the summary of the biocidal product characteristics set out in the Annex.
The Union Authorisation is valid from 8 August 2022 to 31 July 2032.
Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 13 July 2022.
For the Commission
The President
Ursula VON DER LEYEN
(1) OJ L 167, 27.6.2012, p. 1.
(2) ECHA opinion of 13 October 2021 on the Union authorisation of ‘INTEROX Biocidal Product Family 1’ (ECHA/BPC/295/2021), https://echa.europa.eu/bpc-opinions-on-union-authorisation
ANNEX
Summary of product characteristics for a biocidal product family
Interox Biocidal Product Family 1
Product type 2 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants)
Product type 3 - Veterinary hygiene (Disinfectants)
Product type 4 - Food and feed area (Disinfectants)
Authorisation number: EU-0027468-0000
R4BP asset number: EU-0027468-0000
PART I
FIRST INFORMATION LEVEL
1. ADMINISTRATIVE INFORMATION
1.1. Family name
Name |
Interox Biocidal Product Family 1 |
1.2. Product type(s)
Product type(s) |
PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) PT03 - Veterinary hygiene (Disinfectants) PT04 - Food and feed area (Disinfectants) |
1.3. Authorisation holder
Name and address of the authorisation holder |
Name |
SOLVAY CHEMICALS INTERNATIONAL |
Address |
RUE DE RANSBEEK 310, B-1120 BRUXELLES Belgium |
|
Authorisation number |
EU-0027468-0000 |
|
R4BP asset number |
EU-0027468-0000 |
|
Date of the authorisation |
8 August 2022 |
|
Expiry date of the authorisation |
31 July 2032 |
1.4. Manufacturer(s) of the biocidal products
Name of manufacturer |
Solvay Interox Limited |
Address of manufacturer |
Baronet Road, Solvay House, WA4 6HA Warrington United Kingdom |
Location of manufacturing sites |
Solvay Interox Limited, Baronet Road, Solvay House, WA4 6HA Warrington United Kingdom |
Name of manufacturer |
Solvay Chemicals Finland Oy |
Address of manufacturer |
YRJONOJANTIE 2, 45910 VOIKKAA Finland |
Location of manufacturing sites |
Solvay Chemicals Finland Oy, YRJONOJANTIE 2, 45910 VOIKKAA Finland |
Name of manufacturer |
Solvay Chemicals GmbH Germany |
Address of manufacturer |
KOETHENSCHE STRASSE 1-3, 06406 DE BERNBURG Germany |
Location of manufacturing sites |
Solvay Chemicals GmbH Germany, KOETHENSCHE STRASSE 1-3, 06406 DE BERNBURG Germany |
Name of manufacturer |
Solvay Chemie BV Netherlands |
Address of manufacturer |
SCHEPERSWEG, 1, 6049 CV HERTEN Netherlands |
Location of manufacturing sites |
Solvay Chemie BV Netherlands, SCHEPERSWEG, 1, 6049 CV HERTEN Netherlands |
Name of manufacturer |
Solvay Chimica Italia SpA Italy |
Address of manufacturer |
VIA PIAVE, 6 Rosignano SOLVAY, LI 57013 Rosignano Italy |
Location of manufacturing sites |
Solvay Chimica Italia SpA Italy, VIA PIAVE, 6 Rosignano SOLVAY, LI 57013 Rosignano Italy |
Name of manufacturer |
Solvay Chimie SA Belgium |
Address of manufacturer |
Rue de Ransbeek 310, 1120 BE Brussels Belgium |
Location of manufacturing sites |
Solvay Chimie SA Belgium, RUE SOLVAY, 39, 5190 BE JEMEPPE-SUR-SAMBRE Belgium Solvay Chimie SA Belgium, SCHELDELAAN 600 – HAVEN 725, 2040 BE Antwerp Belgium |
Name of manufacturer |
Solvay Interox Produtos Peroxidados SA |
Address of manufacturer |
RUA ENG. CLEMENT DUMOULIN, 2625-106 POVOA DE SANTA IRIA Portugal |
Location of manufacturing sites |
Solvay Interox Produtos Peroxidados SA, RUA ENG. CLEMENT DUMOULIN, 2625-106 POVOA DE SANTA IRIA Portugal |
1.5. Manufacturer(s) of the active substance(s)
Active substance |
Hydrogen peroxide |
Name of manufacturer |
Solvay Interox Limited |
Address of manufacturer |
Baronet Road, Solvay House, WA4 6HA Warrington United Kingdom |
Location of manufacturing sites |
Solvay Interox Limited, Baronet Road, Solvay House, WA4 6HA Warrington United Kingdom |
Active substance |
Hydrogen peroxide |
Name of manufacturer |
Solvay Chemicals Finland Oy |
Address of manufacturer |
YRJONOJANTIE 2, 45910 VOIKKAA Finland |
Location of manufacturing sites |
Solvay Chemicals Finland Oy, YRJONOJANTIE 2, 45910 VOIKKAA Finland |
Active substance |
Hydrogen peroxide |
Name of manufacturer |
Solvay Chemicals GmbH Germany |
Address of manufacturer |
KOETHENSCHE STRASSE 1-3, 06406 BERNBURG Germany |
Location of manufacturing sites |
Solvay Chemicals GmbH Germany, KOETHENSCHE STRASSE 1-3, 06406 BERNBURG Germany |
Active substance |
Hydrogen peroxide |
Name of manufacturer |
Solvay Chimica Italia SpA Italy |
Address of manufacturer |
VIA PIAVE, 6 ROSIGNANO SOLVAY, LI 57013 ROSIGNANO Italy |
Location of manufacturing sites |
Solvay Chimica Italia SpA Italy, VIA PIAVE, 6 ROSIGNANO SOLVAY, LI 57013 ROSIGNANO Italy |
Active substance |
Hydrogen peroxide |
Name of manufacturer |
Solvay Chimie SA Belgium |
Address of manufacturer |
Rue de Ransbeek 310, 1120 Brussels Belgium |
Location of manufacturing sites |
Solvay Chimie SA Belgium, RUE SOLVAY 39, 5190 BE JEMEPPE-SUR-SAMBRE Belgium Solvay Chimie SA Belgium, SCHELDELAAN 600 – HAVEN 725, 2040 BE Antwerp Belgium |
Active substance |
Hydrogen peroxide |
Name of manufacturer |
Solvay Interox Produtos Peroxidados SA |
Address of manufacturer |
RUA ENG. CLEMENT DUMOULIN, 2625-106 POVOA DE SANTA IRIA Portugal |
Location of manufacturing sites |
Solvay Interox Produtos Peroxidados SA, RUA ENG. CLEMENT DUMOULIN, 2625-106 POVOA DE SANTA IRIA Portugal |
2. PRODUCT FAMILY COMPOSITION AND FORMULATION
2.1. Qualitative and quantitative information on the composition of the family
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Min |
Max |
|||||
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
13,0 |
49,9 |
2.2. Type(s) of formulation
Formulation(s) |
SL - Soluble concentrate AL - Any other liquid |
PART II
SECOND INFORMATION LEVEL - META SPC(S)
META SPC 1
1. META SPC 1 ADMINISTRATIVE INFORMATION
1.1. Meta SPC 1 identifier
Identifier |
Meta SPC 1 |
1.2. Suffix to the authorisation number
Number |
1-1 |
1.3. Product type(s)
Product type(s) |
PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) |
2. META SPC 1 COMPOSITION
2.1. Qualitative and quantitative information on the composition of the meta SPC 1
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Min |
Max |
|||||
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
13,0 |
13,5 |
2.2. Type(s) of formulation of the meta SPC 1
Formulation(s) |
AL - Any other liquid |
3. HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 1
Hazard statements |
May intensify fire; oxidiser Causes serious eye damage. |
Precautionary statements |
Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. - No smoking. Keep away from clothing and other combustible materials. Wear eye protection. IF IN EYES:Rinse cautiously with water for several minutes.Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor. In case of fire:Use water to extinguish. Dispose of contents to in accordance with local/regional/national/international regulation. Dispose of container to in accordance with local/regional/national/international regulation. |
4. AUTHORISED USE(S) OF THE META SPC 1
4.1. Use description
Table 1. Use # 1 – Surface disinfection of closed spaces by aerosolised hydrogen peroxide
Product type |
PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) |
Where relevant, an exact description of the authorised use |
Not relevant |
Target organism(s) (including development stage) |
Common name: Bacteria Development stage: Common name: Viruses Development stage: Common name: Fungi/yeasts Development stage: Common name: Bacterial spores Development stage: |
Field(s) of use |
Indoor Indoor, closed spaces. Industrial/pharmaceutical industry or cosmetics industry, for example clean rooms. Medical - healthcare facilities, hospitals and emergency vehicles. Institutional. Disinfection of non-porous surfaces |
Application method(s) |
Method: - Detailed description: Automated, non-directed aerosolization (e.g. fogging or spraying) |
Application rate(s) and frequency |
Application Rate: 13% hydrogen peroxide (undiluted product) applied via aerosolization in closed rooms. Dilution (%): Number and timing of application: Frequency - as required by user, for example up to 3 times per day. Treatment time depends on machine type, size of room or area of surfaces to be disinfected. Apply at room temperature. |
Category(ies) of users |
Professional |
Pack sizes and packaging material |
Pack sizes (L): 0.25, 1, 2.5, 5, 10, 20, 22, 30, 60, 200, 220 and 1000 L Packaging material: Approved grades of HDPE. |
4.1.1. Use-specific instructions for use
Use an automated loading system.
13% (w/w) hydrogen peroxide (undiluted product) is applied via aerosolization by automated device in a sealed room. Rooms may be dehumidified to achieve higher hydrogen peroxide concentrations on surfaces.
Remove barriers that may hinder aerosolized product from reaching the surfaces to be disinfected.
The disinfected surfaces should be non-porous and cleaned before application of the product. The product is not intended to be used on surfaces that may come into contact with food or feeding stuffs.
The user should carry out a microbiological validation of the disinfection in the rooms to be disinfected (or in a suitable "standard room", if applicable) with the devices to be used, after which a protocol for disinfection of these rooms can be made and used thereafter. Each device or specific installation is systematically validated when it is set up. The optimal operating conditions are validated on site (temperature, hygrometry, product to be used, diffusion time, extraction time, etc.). Besides biological validation chemical validation should be performed.
Efficacy of room disinfection was demonstrated according to norm NF T 72-281 by nebulization of 1 g of hydrogen peroxide per cubic meter of room volume in 22 min followed by 180 min contact time at room temperature.
Volume of disinfected space should be 30 - 150 m3.
Median particle size should be <0.5 μm in aerosols used for disinfection
Prevent entry during disinfection process
4.1.2. Use-specific risk mitigation measures
Surfaces in the treatment area must be clean and dry prior to application.
Seal the treatment enclosure (e.g. with tape) to ensure that hydrogen peroxide levels outside the enclosure are kept at acceptable health and safety levels.
Ensure all personnel have vacated the treatment enclosure prior to application. Remove all plants, animals, beverages and food. Re-entry is only permitted once the air concentration has dropped below the reference value (1.25 mg/m3). After the application, the room must be ventilated, preferably by mechanical ventilation. The duration of the ventilation period has to be established by measurement with suitable measurement equipment. In case of the room has to be entered when the hydrogen peroxide concentration is still above 1.25 mg/m3 it is only allowed by wearing appropriate PPE including SCBA (Self Contained Breathing Apparatus).
Place warning signs on all entrances to the treatment enclosure.
4.1.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
See general directions for use.
4.1.4. Where specific to the use, the instructions for safe disposal of the product and its packaging
See general directions for use.
4.1.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage
See general directions for use.
5. GENERAL DIRECTIONS FOR USE (1) OF THE META SPC 1
5.1. Instructions for use
-
5.2. Risk mitigation measures
The use of eye protection during handling of the product is mandatory.
Wear face shield where splashing is possible.
5.3. Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
Particulars of likely direct or indirect adverse effects:
— |
In case of inhalation: Breathing difficulties, cough, pulmonary oedema, nausea, vomiting. |
— |
In case of skin contact: Redness, swelling of tissue, skin irritation. |
— |
In case of eye contact: Redness, lachrymation, swelling of tissue, severe burns. |
— |
In case of ingestion: Nausea, abdominal pain, bloody vomiting, diarrhoea, suffocation, cough, severe shortness of breath, severe burns of the mouth and throat, as well as a danger of perforation of the oesophagus and the stomach. Risk of respiratory disorder. |
First aid instructions:
|
IF INHALED: If symptoms occur call a POISON CENTRE or a doctor. |
|
IF ON SKIN: Immediately wash skin with plenty of water. Thereafter take off all contaminated clothing and wash it before reuse. Continue to wash the skin with water for 15 minutes. Call a POISON CENTRE or a doctor. |
|
IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing for at least 15 minutes. Call 112/ambulance for medical assistance. |
|
IF SWALLOWED: Immediately rinse mouth. Give something to drink, if exposed person is able to swallow. Do NOT induce vomiting. Call 112/ambulance for medical assistance. |
Emergency measures to protect environment in case of accident:
— |
Environmental precautions: Should not be released into the environment. If the product contaminates rivers and lakes or drains inform respective authorities. |
— |
Methods and materials for containment and cleaning up: Dilute with plenty of water. Dam up. Do not mix waste streams during collection. Soak up with inert absorbent material. Keep in properly labelled containers. Keep in suitable, closed containers for disposal. Never return spills in original containers for use. |
5.4. Instructions for safe disposal of the product and its packaging
Do not allow undiluted product to enter the sewer. Do not discharge unused product on the ground, into water courses, into pipes (sink, toilets…) nor down the drains. Only pass on empty containers/packaging for recycling. Disposal of packaging should at all times comply with the waste disposal legislation and any regional local authority requirements.
5.5. Conditions of storage and shelf-life of the product under normal conditions of storage
Storage: Hydrogen peroxide should be stored in properly designed bulk storage tanks or in original vented container in upright position away from incompatible products. Use only approved materials of construction for equipment or approved packs. Store in a cool, ventilated area and protect from damage and direct sunlight. Do not store at temperatures above 40 °C. Keep away from combustible materials and sources of ignition and heat.
Shelf-life: 12 months in HDPE packs at ambient temperature.
6. OTHER INFORMATION
Please be aware of the European reference value of 1.25 mg/m3 for the active substance hydrogen peroxide (CAS No.: 7722-84-1) which was used for the risk assessment for this product.
7. THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 1
7.1. Trade name(s), authorisation number and specific composition of each individual product
Trade name(s) |
INTEROX SG 12 |
Market area: EU |
||||
Authorisation number |
EU-0027468-0001 1-1 |
|||||
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
13,5 |
META SPC 2
1. META SPC 2 ADMINISTRATIVE INFORMATION
1.1. Meta SPC 2 identifier
Identifier |
Meta SPC 2 |
1.2. Suffix to the authorisation number
Number |
1-2 |
1.3. Product type(s)
Product type(s) |
PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) |
2. META SPC 2 COMPOSITION
2.1. Qualitative and quantitative information on the composition of the meta SPC 2
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Min |
Max |
|||||
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
35,0 |
35,7 |
2.2. Type(s) of formulation of the meta SPC 2
Formulation(s) |
AL - Any other liquid |
3. HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 2
Hazard statements |
May intensify fire; oxidiser Harmful if swallowed. Causes skin irritation. Causes serious eye damage. May cause respiratory irritation. Harmful to aquatic life with long lasting effects. |
Precautionary statements |
Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. - No smoking. Keep away from clothing and other combustible materials. Avoid breathing vapours. Wash hands thoroughly after handling. Do no eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Avoid release to the environment. Wear protective gloves. Wear protective clothing. Wear eye protection. Wear face protection. IF SWALLOWED:Call a POISON CENTER/doctor if you feel unwell. IF ON SKIN:Wash with plenty of water. IF INHALED:Remove person to fresh air and keep comfortable for breathing. IF IN EYES:Rinse cautiously with water for several minutes.Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor. Rinse mouth. If skin irritation occurs:Get medical advice. If skin irritation occurs:Get medical attention. Take off contaminated clothing.And wash it before reuse. In case of fire:Use water to extinguish. Store in a well-ventilated place.Keep container tightly closed. Store locked up. Dispose of contents to ...in accordance with all local, regional, national and international regulations.. Dispose of container to in accordance with local/regional/national/international regulation. |
4. AUTHORISED USE(S) OF THE META SPC 2
4.1. Use description
Table 2. Use # 1 – Surface disinfection of closed spaces by aerosolised hydrogen peroxide
Product type |
PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) |
Where relevant, an exact description of the authorised use |
Not relevant |
Target organism(s) (including development stage) |
Common name: Bacteria Development stage: Common name: Fungi/yeasts Development stage: Common name: Viruses Development stage: Common name: bacterial spores Development stage: |
Field(s) of use |
Indoor Indoor, closed spaces Industrial – pharmaceutical industry or cosmetics industry, for example clean rooms. Medical– healthcare facilities, hospitals, emergency vehicles. Institutional. Disinfection of non-porous surfaces. |
Application method(s) |
Method: - Detailed description: Automated, non-directed aerosolization (e.g. fogging or spraying) |
Application rate(s) and frequency |
Application Rate: 35% hydrogen peroxide (undiluted product) applied via aerosolization in closed rooms. Dilution (%): Number and timing of application: Frequency - as required by user, for example up to 3 times per day. Treatment time depends on machine type, size of room or area of surfaces to be disinfected. Apply at room temperature. |
Category(ies) of users |
Professional |
Pack sizes and packaging material |
Pack sizes (L): 0.25, 1, 2.5, 5, 10, 20, 22, 30, 60, 200, 220 and 1000 L Packaging material: Approved grades of HDPE. |
4.1.1. Use-specific instructions for use
Use an automated loading system.
35% (w/w) hydrogen peroxide (undiluted product) is applied via aerosolization by automated device in a sealed room. Rooms may be dehumidified to achieve higher hydrogen peroxide concentrations on surfaces.
Remove barriers that may hinder aerosolized product from reaching the surfaces to be disinfected.
The disinfected surfaces should be non-porous and cleaned before application of the product. The product is not intended to be used on surfaces that may come into contact with food or feeding stuffs.
The user should carry out a microbiological validation of the disinfection in the rooms to be disinfected (or in a suitable "standard room", if applicable) with the devices to be used, after which a protocol for disinfection of these rooms can be made and used thereafter. Each device or specific installation is systematically validated when it is set up. The optimal operating conditions are validated on site (temperature, hygrometry, product to be used, diffusion time, extraction time, etc.). Besides biological validation chemical validation should be performed.
Efficacy of room disinfection was demonstrated according to norm NF T 72-281 by nebulization of 1 g of hydrogen peroxide per cubic meter of room volume in 22 min followed by 180 min contact time at room temperature.
Volume of disinfected space should be 30 - 150 m3.
Median particle size should be <0.5 μm in aerosols used for disinfection.
Prevent entry during disinfection process.
4.1.2. Use-specific risk mitigation measures
Surfaces in the treatment area must be clean and dry prior to application.
Seal the treatment enclosure (e.g. with tape) to ensure that hydrogen peroxide levels outside the enclosure are kept at acceptable health and safety levels.
Ensure all personnel have vacated the treatment enclosure prior to application. Remove all plants, animals, beverages and food. Re-entry is only permitted once the air concentration has dropped below the reference value (1.25 mg/m3). After the application, the room must be ventilated, preferably by mechanical ventilation. The duration of the ventilation period has to be established by measurement with suitable measurement equipment. In case the room has to be entered when the hydrogen peroxide concentration is still above 1.25 mg/m3 it is only allowed by wearing appropriate PPE including SCBA (Self Contained Breathing Apparatus).
Place warning signs on all entrances to the treatment enclosure.
4.1.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
See general directions for use.
4.1.4. Where specific to the use, the instructions for safe disposal of the product and its packaging
See general directions for use.
4.1.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage
See general directions for use.
4.2. Use description
Table 3. Use # 2 – Surface disinfection of enclosures in filling isolators by aerosolised or vaporised hydrogen peroxide (VHP)
Product type |
PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) |
Where relevant, an exact description of the authorised use |
Not relevant |
Target organism(s) (including development stage) |
Common name: Bacteria Development stage: Common name: bacterial spores Development stage: Common name: Fungi/yeasts Development stage: Common name: Viruses Development stage: |
Field(s) of use |
Indoor Indoor. Industrial – aseptic chambers in aseptic filling applied in pharmaceutical or cosmetics industry. Disinfection of non-porous surfaces. |
Application method(s) |
Method: - Detailed description: Automated, non-directed aerosolization (e.g. fogging or spraying, flash evaporation) |
Application rate(s) and frequency |
Application Rate: 35% hydrogen peroxide (undiluted product) applied via flash evaporation or aerosolization in filling isolators. Dilution (%): Number and timing of application: Frequency – as required by user, for example 1 or 2 times per day/week. |
Category(ies) of users |
Professional |
Pack sizes and packaging material |
Pack sizes (L): 0.25, 1, 2.5, 5, 10, 20, 22, 30, 60, 200, 220 and 1000 L. Packaging material: Approved grades of HDPE |
4.2.1. Use-specific instructions for use
Use an automated loading system.
35% (w/w) hydrogen peroxide (undiluted product) is applied via flash evaporation or aerosolization by automated device connected to an filling isolator. Filling isolators may be dehumidified to achieve higher hydrogen peroxide concentrations on surfaces.
The disinfected surfaces should be non-porous and cleaned before application of the product. The product is not intended to be used on surfaces that may come into contact with food or feeding stuffs.
The user should carry out a microbiological validation of the disinfection in the enclosures to be disinfected with the devices to be used, after which a protocol for disinfection of these enclosures can be made and used thereafter. Each device or specific installation is systematically validated when it is set up. The optimal operating conditions are validated on site (temperature, hygrometry, product to be used, diffusion time, extraction time, etc.). Besides biological validation chemical validation should be performed.
Efficacy of use against bacterial spores was demonstrated by flash evaporation of hydrogen peroxide at a rate of 0.35 g/m3/min for 51 min (18 g hydrogen peroxide / m3 / treatment).
Volume of disinfected enclosure should be 15 - 150 m3.
Median particle size should be <0.5 μm in aerosols used for disinfection.
Prevent entry during disinfection process.
4.2.2. Use-specific risk mitigation measures
Surfaces in the treatment area must be clean and dry prior to application.
Seal the treatment enclosure (e.g. with tape) to ensure that hydrogen peroxide levels outside the enclosure are kept at acceptable health and safety levels.
Ensure all personnel have vacated the treatment enclosure prior to application. Remove all plants, animals, beverages and food. Re-entry is only permitted once the air concentration has dropped below the reference value (1.25 mg/m3).
After the application, the room must be ventilated, preferably by mechanical ventilation. The duration of the ventilation period has to be established by measurement with suitable measurement equipment. In case the room has to be entered when the hydrogen peroxide concentration is still above 1.25 mg/m3 it is only allowed by wearing appropriate PPE including SCBA (Self Contained Breathing Apparatus).
Place warning signs on all entrances to the treatment enclosure.
4.2.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
See general directions for use.
4.2.4. Where specific to the use, the instructions for safe disposal of the product and its packaging
See general directions for use.
4.2.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage
See general directions for use.
5. GENERAL DIRECTIONS FOR USE (2) OF THE META SPC 2
5.1. Instructions for use
-
5.2. Risk mitigation measures
The use of eye protection during handling of the product is mandatory.
Wear face shield where splashing is possible.
5.3. Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
Particulars of likely direct or indirect adverse effects:
— |
In case of inhalation: Breathing difficulties, cough, pulmonary oedema, nausea, vomiting. |
— |
In case of skin contact: Redness, swelling of tissue, skin irritation. |
— |
In case of eye contact: Redness, lachrymation, swelling of tissue, severe burns. |
— |
In case of ingestion: Nausea, abdominal pain, bloody vomiting, diarrhoea, suffocation, cough, severe shortness of breath, severe burns of the mouth and throat, as well as a danger of perforation of the oesophagus and the stomach. Risk of respiratory disorder. |
First aid instructions:
|
IF INHALED: Move to fresh air and keep at rest in a position comfortable for breathing. If symptoms: Call 112/ambulance for medical assistance. If no symptoms: Call a POISON CENTRE or a doctor. |
|
IF ON SKIN: Immediately wash skin with plenty of water. Thereafter take off all contaminated clothing and wash it before reuse. Continue to wash the skin with water for 15 minutes. Call a POISON CENTRE or a doctor. |
|
IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing for at least 15 minutes. Call 112/ambulance for medical assistance. |
|
IF SWALLOWED: Immediately rinse mouth. Give something to drink, if exposed person is able to swallow. Do NOT induce vomiting. Call 112/ambulance for medical assistance. |
Emergency measures to protect environment in case of accident:
— |
Environmental precautions: Should not be released into the environment. If the product contaminates rivers and lakes or drains inform respective authorities. |
— |
Methods and materials for containment and cleaning up: Dilute with plenty of water. Dam up. Do not mix waste streams during collection. Soak up with inert absorbent material. Keep in properly labelled containers. Keep in suitable, closed containers for disposal. Never return spills in original containers for re-use. |
5.4. Instructions for safe disposal of the product and its packaging
Do not allow undiluted product to enter the sewer. Do not discharge unused product on the ground, into water courses, into pipes (sink, toilets…) nor down the drains. Only pass on empty containers/packaging for recycling. Disposal of packaging should at all times comply with the waste disposal legislation and any regional local authority requirements.
5.5. Conditions of storage and shelf-life of the product under normal conditions of storage
Storage: Hydrogen peroxide should be stored in properly designed bulk storage tanks or in original vented container in upright position away from incompatible products. Use only approved materials of construction for equipment or approved packs. Store in a cool, ventilated area and protect from damage and direct sunlight. Do not store at temperatures above 40 °C. Keep away from combustible materials and sources of ignition and heat.
Shelf-life: 12 months in HDPE packs at ambient temperature.
6. OTHER INFORMATION
Please be aware of the European reference value of 1.25 mg/m3 for the active substance hydrogen peroxide (CAS No.: 7722-84-1) which was used for the risk assessment for this product.
7. THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 2
7.1. Trade name(s), authorisation number and specific composition of each individual product
Trade name(s) |
INTEROX SG 35 |
Market area: EU |
||||
Authorisation number |
EU-0027468-0002 1-2 |
|||||
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
35,7 |
7.2. Trade name(s), authorisation number and specific composition of each individual product
Trade name(s) |
INTEROX SG 35 PLUS |
Market area: EU |
||||
Authorisation number |
EU-0027468-0003 1-2 |
|||||
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
35,7 |
META SPC 3
1. META SPC 3 ADMINISTRATIVE INFORMATION
1.1. Meta SPC 3 identifier
Identifier |
Meta SPC 3 |
1.2. Suffix to the authorisation number
Number |
1-3 |
1.3. Product type(s)
Product type(s) |
PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) |
2. META SPC 3 COMPOSITION
2.1. Qualitative and quantitative information on the composition of the meta SPC 3
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Min |
Max |
|||||
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
49,0 |
49,9 |
2.2. Type(s) of formulation of the meta SPC 3
Formulation(s) |
AL - Any other liquid |
3. HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 3
Hazard statements |
May intensify fire; oxidiser Harmful if swallowed. Causes severe skin burns and eye damage. May cause respiratory irritation. Harmful to aquatic life with long lasting effects. |
Precautionary statements |
Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. - No smoking. Keep away from clothing and other combustible materials. Do not breathe vapours. Wash hands thoroughly after handling. Do no eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Avoid release to the environment. Wear protective gloves. Wear protective clothing. Wear eye protection. Wear face protection. IF SWALLOWED:Call a POISON CENTER/doctor if you feel unwell. IF SWALLOWED:Rinse mouth.Do NOT induce vomiting. IF ON SKIN (or hair):Take off immediately all contaminated clothing.Rinse skin with water. IF INHALED:Remove person to fresh air and keep comfortable for breathing. IF IN EYES:Rinse cautiously with water for several minutes.Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor. Wash contaminated clothing before reuse. In case of fire:Use water to extinguish. Store in a well-ventilated place.Keep container tightly closed. Store locked up. Dispose of contents to ...in accordance with all local, regional, national and international regulations. Dispose of container to in accordance with local/regional/national/international regulation. |
4. AUTHORISED USE(S) OF THE META SPC 3
4.1. Use description
Table 4. Use # 1 – Surface disinfection of closed spaces by aerosolised hydrogen peroxide
Product type |
PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) |
Where relevant, an exact description of the authorised use |
Not relevant |
Target organism(s) (including development stage) |
Common name: Bacteria Development stage: Common name: Fungi/yeasts Development stage: Common name: Viruses Development stage: Common name: Bacterial Spores Development stage: |
Field(s) of use |
Indoor Indoor, closed spaces. Industrial – pharmaceutical industry or cosmetics industry, for example clean rooms. Medical– healthcare facilities, hospitals, emergency vehicles. Institutional. Disinfection of non-porous surfaces. |
Application method(s) |
Method: - Detailed description: Automated, non-directed aerosolization (e.g. fogging or spraying). |
Application rate(s) and frequency |
Application Rate: 49% hydrogen peroxide (undiluted product) applied via aerosolization in closed rooms. Dilution (%): Number and timing of application: Frequency - as required by user, for example up to 3 times per day. Treatment time depends on machine type, size of room or area of surfaces to be disinfected. Apply at room temperature. |
Category(ies) of users |
Professional |
Pack sizes and packaging material |
Pack sizes (L): 0.25, 1, 2.5, 5, 10, 20, 22, 30, 60, 200, 220 and 1000 L Packaging material: Approved grades of HDPE. |
4.1.1. Use-specific instructions for use
Use an automated loading system.
49% (w/w) hydrogen peroxide (undiluted product) is applied via aerosolization by automated device in a sealed room. Rooms may be dehumidified to achieve higher hydrogen peroxide concentrations on surfaces.
Remove barriers that may hinder aerosolized product from reaching the surfaces to be disinfected.
The disinfected surfaces should be non-porous and cleaned before application of the product. The product is not intended to be used on surfaces that may come into contact with food or feeding stuffs.
The user should carry out a microbiological validation of the disinfection in the rooms to be disinfected (or in a suitable "standard room", if applicable) with the devices to be used, after which a protocol for disinfection of these rooms can be made and used thereafter. Each device or specific installation is systematically validated when it is set up. The optimal operating conditions are validated on site (temperature, hygrometry, product to be used, diffusion time, extraction time, etc.). Besides biological validation chemical validation should be performed.
Efficacy of room disinfection was demonstrated according to norm NF T 72-281by nebulization of 1 g of hydrogen peroxide per cubic meter of room volume in 22 min followed by 180 min contact time at room temperature.
Volume of disinfected space should be 30 - 150 m3.
Median particle size should be <0.5 μm in aerosols used for disinfection.
Prevent entry during disinfection process.
4.1.2. Use-specific risk mitigation measures
Surfaces in the treatment area must be clean and dry prior to application.
Seal the treatment enclosure (e.g. with tape) to ensure that hydrogen peroxide levels outside the enclosure are kept at acceptable health and safety levels.
Ensure all personnel have vacated the treatment enclosure prior to application. Remove all plants, animals, beverages and food. Re-entry is only permitted once the air concentration has dropped below the reference value (1.25 mg/m3). After the application, the room must be ventilated, preferably by mechanical ventilation. The duration of the ventilation period has to be established by measurement with suitable measurement equipment. In case the room has to be entered when the hydrogen peroxide concentration is still above 1.25 mg/m3 it is only allowed by wearing appropriate PPE including SCBA (Self Contained Breathing Apparatus).
Place warning signs on all entrances to the treatment enclosure.
4.1.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
See general directions for use.
4.1.4. Where specific to the use, the instructions for safe disposal of the product and its packaging
See general directions for use.
4.1.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage
See general directions for use.
4.2. Use description
Table 5. Use # 2 – Surface disinfection of enclosures in filling isolators by aerosolised or vaporised hydrogen peroxide (VHP)
Product type |
PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) |
Where relevant, an exact description of the authorised use |
Not relevant |
Target organism(s) (including development stage) |
Common name: Bacteria Development stage: Common name: bacterial spores Development stage: Common name: Fungi/yeasts Development stage: Common name: Viruses Development stage: |
Field(s) of use |
Indoor Indoor. Industrial – aseptic chambers in aseptic filling applied in pharmaceutical or cosmetics industry. Disinfection of non-porous surfaces. |
Application method(s) |
Method: - Detailed description: Automated, non-directed aerosolization (e.g. fogging or spraying, flash evaporation) |
Application rate(s) and frequency |
Application Rate: 49% hydrogen peroxide (undiluted product) applied via flash evaporation or aerosolization in filling isolators. Dilution (%): Number and timing of application: Frequency – as required by user, for example 1 or 2 times per day/week. |
Category(ies) of users |
Professional |
Pack sizes and packaging material |
Pack sizes (L): 0.25, 1, 2.5, 5, 10, 20, 22, 30, 60, 200, 220 and 1000 L. Packaging material: Approved grades of HDPE. |
4.2.1. Use-specific instructions for use
Use an automated loading system.
49% (w/w) hydrogen peroxide (undiluted product) is applied via flash evaporation or aerosolization by automated device connected to an filling isolator. Filling isolators may be dehumidified to achieve higher hydrogen peroxide concentrations on surfaces.
The disinfected surfaces should be non-porous and cleaned before application of the product. The product is not intended to be used on surfaces that may come into contact with food or feeding stuffs.
The user should carry out a microbiological validation of the disinfection in the enclosures to be disinfected with the devices to be used, after which a protocol for disinfection of these enclosures can be made and used thereafter. Each device or specific installation is systematically validated when it is set up. The optimal operating conditions are validated on site (temperature, hygrometry, product to be used, diffusion time, extraction time, etc.). Besides biological validation chemical validation should be performed.
Efficacy of use against bacterial spores was demonstrated by flash evaporation of hydrogen peroxide at a rate of 0.35 g/m3/min for 51 min (18 g hydrogen peroxide / m3 / treatment).
Volume of disinfected enclosure should be 15 - 150 m3.
Median particle size should be <0.5 μm in aerosols used for disinfection.
Prevent entry during disinfection process.
4.2.2. Use-specific risk mitigation measures
Surfaces in the treatment area must be clean and dry prior to application.
Seal the treatment enclosure (e.g. with tape) to ensure that hydrogen peroxide levels outside the enclosure are kept at acceptable health and safety levels.
Ensure all personnel have vacated the treatment enclosure prior to application. Remove all plants, animals, beverages and food. Re-entry is only permitted once the air concentration has dropped below the reference value (1.25 mg/m3).
After the application, the room must be ventilated, preferably by mechanical ventilation. The duration of the ventilation period has to be established by measurement with suitable measurement equipment. In case the room has to be entered when the hydrogen peroxide concentration is still above 1.25 mg/m3 it is only allowed by wearing appropriate PPE including SCBA (Self Contained Breathing Apparatus).
Place warning signs on all entrances to the treatment enclosure.
4.2.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
See general directions for use.
4.2.4. Where specific to the use, the instructions for safe disposal of the product and its packaging
See general directions for use.
4.2.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage
See general directions for use.
5. GENERAL DIRECTIONS FOR USE (3) OF THE META SPC 3
5.1. Instructions for use
-
5.2. Risk mitigation measures
The use of eye protection during handling of the product is mandatory.
Wear face shield where splashing is possible.
5.3. Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
Particulars of likely direct or indirect adverse effects:
— |
In case of inhalation: Breathing difficulties, cough, pulmonary oedema, nausea, vomiting. |
— |
In case of skin contact: Redness, swelling of tissue, skin irritation. |
— |
In case of eye contact: Redness, lachrymation, swelling of tissue, severe burns. |
— |
In case of ingestion: Nausea, abdominal pain, bloody vomiting, diarrhoea, suffocation, cough, severe shortness of breath, severe burns of the mouth and throat, as well as a danger of perforation of the oesophagus and the stomach. Risk of respiratory disorder. |
First aid instructions:
|
IF INHALED: Move to fresh air and keep at rest in a position comfortable for breathing. If symptoms: Call 112/ambulance for medical assistance. If no symptoms: Call a POISON CENTRE or a doctor. |
|
IF ON SKIN: Immediately wash skin with plenty of water. Thereafter take off all contaminated clothing and wash it before reuse. Continue to wash the skin with water for 15 minutes. Call a POISON CENTRE or a doctor. |
|
IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing for at least 15 minutes. Call 112/ambulance for medical assistance. |
|
IF SWALLOWED: Immediately rinse mouth. Give something to drink, if exposed person is able to swallow. Do NOT induce vomiting. Call 112/ambulance for medical assistance. |
Emergency measures to protect environment in case of accident:
— |
Environmental precautions: Should not be released into the environment. If the product contaminates rivers and lakes or drains inform respective authorities. |
— |
Methods and materials for containment and cleaning up: Dilute with plenty of water. Dam up. Do not mix waste streams during collection. Soak up with inert absorbent material. Keep in properly labelled containers. Keep in suitable, closed containers for disposal. Never return spills in original containers for re-use. |
5.4. Instructions for safe disposal of the product and its packaging
Do not allow undiluted product to enter the sewer. Do not discharge unused product on the ground, into water courses, into pipes (sink, toilets…) nor down the drains. Only pass on empty containers/packaging for recycling. Disposal of packaging should at all times comply with the waste disposal legislation and any regional local authority requirements.
5.5. Conditions of storage and shelf-life of the product under normal conditions of storage
Storage: Hydrogen peroxide should be stored in properly designed bulk storage tanks or in original vented container in upright position away from incompatible products. Use only approved materials of construction for equipment or approved packs. Store in a cool, ventilated area and protect from damage and direct sunlight. Do not store at temperatures above 40 °C. Keep away from combustible materials and sources of ignition and heat.
Shelf-life: 12 months in HDPE packs at ambient temperature.
6. OTHER INFORMATION
Please be aware of the European reference value of 1.25 mg/m3 for the active substance hydrogen peroxide (CAS No.: 7722-84-1) which was used for the risk assessment for this product.
7. THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 3
7.1. Trade name(s), authorisation number and specific composition of each individual product
Trade name(s) |
Interox SG 50 |
Market area: EU |
||||
Authorisation number |
EU-0027468-0004 1-3 |
|||||
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
49,9 |
7.2. Trade name(s), authorisation number and specific composition of each individual product
Trade name(s) |
INTEROX SG 50 PLUS |
Market area: EU |
||||
Authorisation number |
EU-0027468-0005 1-3 |
|||||
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
49,9 |
META SPC 4
1. META SPC 4 ADMINISTRATIVE INFORMATION
1.1. Meta SPC 4 identifier
Identifier |
Meta SPC 4 |
1.2. Suffix to the authorisation number
Number |
1-4 |
1.3. Product type(s)
Product type(s) |
PT04 - Food and feed area (Disinfectants) |
2. META SPC 4 COMPOSITION
2.1. Qualitative and quantitative information on the composition of the meta SPC 4
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Min |
Max |
|||||
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
25,0 |
25,7 |
2.2. Type(s) of formulation of the meta SPC 4
Formulation(s) |
AL - Any other liquid |
3. HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 4
Hazard statements |
May intensify fire; oxidiser Harmful if swallowed. Causes serious eye damage. Harmful to aquatic life with long lasting effects. |
Precautionary statements |
Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. - No smoking. Keep away from clothing and other combustible materials. Wash hands thoroughly after handling. Do no eat, drink or smoke when using this product. Avoid release to the environment. Wear eye protection. IF SWALLOWED:Call a POISON CENTER/doctor if you feel unwell. IF IN EYES:Rinse cautiously with water for several minutes.Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/doctor. Rinse mouth. In case of fire:Use water to extinguish. Store in a well-ventilated place.Keep container tightly closed. Store locked up. Dispose of contents to ….in accordance with all local, regional, national and international regulations.. Dispose of container to in accordance with local/regional/national/international regulation. |
4. AUTHORISED USE(S) OF THE META SPC 4
4.1. Use description
Table 6. Use # 1 – Disinfection of polyethylene terephthalate food packages by vaporised hydrogen peroxide (VHP)
Product type |
PT04 - Food and feed area (Disinfectants) |
Where relevant, an exact description of the authorised use |
Not relevant |
Target organism(s) (including development stage) |
Common name: Bacterial Spores Development stage: |
Field(s) of use |
Indoor Industrial use - food and feed area. Disinfection of food package material. |
Application method(s) |
Method: - Detailed description: Automated vaporization in aseptic filling machines |
Application rate(s) and frequency |
Application Rate: Undiluted product (25 % w/w hydrogen peroxide) vaporized 400 g/h/packaging machine. Dilution (%): Number and timing of application: Number and timing of applications as required by user. Machines typically operate up to 120 hours per week. |
Category(ies) of users |
Professional |
Pack sizes and packaging material |
HDPE packaging: 0.25, 1, 2.5, 5, 10, 20, 22, 30, 60, 200, 220 and 1000 L (IBC). Approved grades of HDPE. |
4.1.1. Use-specific instructions for use
Use an automated loading system.
Use undiluted product (25 % w/w hydrogen peroxide) to disinfect polyethylene terephthalate food packages used in aseptic packaging in food industry..
Follow machine operating instructions for disinfection period, extraction of hydrogen peroxide and re-entry. Prevent entry during disinfection process. Efficacy was demonstrated with a packaging machine running at 12 480 bottles per hour with a production consumption rate of 400 g/h.
Disinfection performance of each packaging machine should be validated using biological and chemical indicators.
After sterilisation, blow-dry the packaging with hot sterile air.
4.1.2. Use-specific risk mitigation measures
During operation, ensure adequate ventilation along the machines (LEV) and in the industrial halls (technical ventilation).
During manual maintenance tasks, ensure adequate ventilation inside the machine (LEV) before opening the doors of the aseptic area.
1 |
The product shall only be transferred in closed pipes after mixing and loading. Open product and waste water flows are not allowed. |
2. |
Workplace release measurements with suitable measurement equipment shall be performed upon implementation of the aseptic packaging plant, at regular intervals (annual intervals recommended) and after any change in relevant boundary conditions. The national regulations for workplace measurements have to be followed. |
3. |
In case of maintenance of the aseptic packaging plant (e.g. manual cleaning, technical incidents or repair) appropriate PPE (respiratory protective equipment, chemical protective gloves, chemical protective coverall (at least type 6), eye protection) is required. The type of RPE and the filter type (code letter, colour) are to be specified by the authorisation holder within the product information. Glove material to be specified by the authorisation holder within the product information.
Use only in closed aseptic packaging machines with no emission to water and negligible emission to air. Hydrogen peroxide emission to air should be controlled by the machine e.g. with catalytic treatment or through a gas scrubber. |
4.1.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
See general directions for use.
4.1.4. Where specific to the use, the instructions for safe disposal of the product and its packaging
See general directions for use.
4.1.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage
See general directions for use.
5. GENERAL DIRECTIONS FOR USE (4) OF THE META SPC 4
5.1. Instructions for use
-
5.2. Risk mitigation measures
The use of eye protection during handling of the product is mandatory.
Wear face shield where splashing is possible.
5.3. Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
Particulars of likely direct or indirect adverse effects:
— |
In case of inhalation: Breathing difficulties, cough, pulmonary oedema, nausea, vomiting. |
— |
In case of skin contact: Redness, swelling of tissue, skin irritation. |
— |
In case of eye contact: Redness, lachrymation, swelling of tissue, severe burns. |
— |
In case of ingestion: Nausea, abdominal pain, bloody vomiting, diarrhoea, suffocation, cough, severe shortness of breath, severe burns of the mouth and throat, as well as a danger of perforation of the oesophagus and the stomach. Risk of respiratory disorder. |
First aid instructions:
|
IF INHALED: If symptoms occur call a POISON CENTRE or a doctor. |
|
IF ON SKIN: Immediately wash skin with plenty of water. Thereafter take off all contaminated clothing and wash it before reuse. Continue to wash the skin with water for 15 minutes. Call a POISON CENTRE or a doctor. |
|
IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing for at least 15 minutes. Call 112/ambulance for medical assistance. |
|
IF SWALLOWED: Immediately rinse mouth. Give something to drink, if exposed person is able to swallow. Do NOT induce vomiting. Call 112/ambulance for medical assistance. |
Emergency measures to protect environment in case of accident:
— |
Environmental precautions: Should not be released into the environment. If the product contaminates rivers and lakes or drains inform respective authorities. |
— |
Methods and materials for containment and cleaning up: Dilute with plenty of water. Dam up. Do not mix waste streams during collection. Soak up with inert absorbent material. Keep in properly labelled containers. Keep in suitable, closed containers for disposal. Never return spills in original containers for re-use. |
5.4. Instructions for safe disposal of the product and its packaging
Do not allow undiluted product to enter the sewer. Do not discharge unused product on the ground, into water courses, into pipes (sink, toilets…) nor down the drains. Only pass on empty containers/packaging for recycling. Disposal of packaging should at all times comply with the waste disposal legislation and any regional local authority requirements.
5.5. Conditions of storage and shelf-life of the product under normal conditions of storage
Storage: Hydrogen peroxide should be stored in properly designed bulk storage tanks or in original vented container in upright position away from incompatible products. Use only approved materials of construction for equipment or approved packs. Store in a cool, ventilated area and protect from damage and direct sunlight. Do not store at temperatures above 40°C. Keep away from combustible materials and sources of ignition and heat.
Shelf-life: 12 months in HDPE packs at ambient temperature.
6. OTHER INFORMATION
Please be aware of the European reference value of 1.25 mg/m3 for the active substance hydrogen peroxide (CAS No.: 7722-84-1) which was used for the risk assessment for this product.
7. THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 4
7.1. Trade name(s), authorisation number and specific composition of each individual product
Trade name(s) |
INTEROX AG Spray 25S |
Market area: EU |
||||
Authorisation number |
EU-0027468-0006 1-4 |
|||||
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
25,7 |
META SPC 5
1. META SPC 5 ADMINISTRATIVE INFORMATION
1.1. Meta SPC 5 identifier
Identifier |
Meta SPC 5 |
1.2. Suffix to the authorisation number
Number |
1-5 |
1.3. Product type(s)
Product type(s) |
PT04 - Food and feed area (Disinfectants) |
2. META SPC 5 COMPOSITION
2.1. Qualitative and quantitative information on the composition of the meta SPC 5
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Min |
Max |
|||||
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
35,0 |
35,7 |
2.2. Type(s) of formulation of the meta SPC 5
Formulation(s) |
AL - Any other liquid |
3. HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 5
Hazard statements |
May intensify fire; oxidiser Harmful if swallowed. Causes skin irritation. Causes serious eye damage. May cause respiratory irritation. Harmful to aquatic life with long lasting effects. |
Precautionary statements |
Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. - No smoking. Keep away from clothing and other combustible materials. Avoid breathing vapours. Wash hands thoroughly after handling. Do no eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Avoid release to the environment. Wear protective gloves. Wear protective clothing. Wear eye protection. Wear face protection. IF SWALLOWED:Call a POISON CENTER/doctor if you feel unwell. IF ON SKIN:Wash with plenty of water. IF INHALED:Remove person to fresh air and keep comfortable for breathing. IF IN EYES:Rinse cautiously with water for several minutes.Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor. Rinse mouth. If skin irritation occurs:Get medical advice. If skin irritation occurs:Get medical attention. Take off contaminated clothing.And wash it before reuse. In case of fire:Use water to extinguish. Store in a well-ventilated place.Keep container tightly closed. Store locked up. Dispose of contents to ….in accordance with all local, regional, national and international regulations.. Dispose of container to in accordance with local/regional/national/international regulation. |
4. AUTHORISED USE(S) OF THE META SPC 5
4.1. Use description
Table 7. Use # 1 – Disinfection of food packaging material (aseptic packaging) by immersion or aerosolised or vaporised hydrogen peroxide (VHP)
Product type |
PT04 - Food and feed area (Disinfectants) |
Where relevant, an exact description of the authorised use |
Not relevant |
Target organism(s) (including development stage) |
Common name: Bacterial Spores Development stage: |
Field(s) of use |
Indoor Industrial use - food and feed area. Disinfection of food package material. |
Application method(s) |
Method: - Detailed description: Automated immersion of packaging material into bath of heated product in aseptic filling machine. Automated vaporisation or aerosolisation of product in sealed area in aseptic filling machine. |
Application rate(s) and frequency |
Application Rate: Undiluted product (35 % w/w hydrogen peroxide) is used. Product consumption in vapour and aerosol applications 0.1 – 1 mL per second per packaging line while the machine is operating. Dilution (%): Number and timing of application: Number and timing of applications as required by user. Machines typically operate up to 120 hours per week. |
Category(ies) of users |
Professional |
Pack sizes and packaging material |
HDPE packaging: 0.25, 1, 2.5, 5, 10, 20, 22, 30, 60, 200, 220 and 1000 L (IBC). Approved grades of HDPE. |
4.1.1. Use-specific instructions for use
Use an automated loading system.
Immersion: immerse clean packaging material in undiluted product according to packaging machine operating instruction Disinfection efficacy is determined by immersion time and temperature and packaging material.
Efficacy was demonstrated by immersion of carton food packages in 80 °C bath for 2.5 s.
If concentration of hydrogen peroxide in the bath drops to less than 32% during operation, replace solution with fresh product.
Vaporization: vaporize and apply undiluted product to clean packaging material according to packaging machine operating instructions. Product vaporized at 100-250 °C. Efficacy was demonstrated with polyethylene terephthalate packages flushed with 100 °C air containing 1.1% (w/w) of product for 5.5 s.
After sterilisation, blow-dry the packaging with hot sterile air.
Suitable packaging materials included paperboard, polyethylene terephthalate, polystyrene and aluminium.
Disinfection performance of each packaging machine should be validated using biological and chemical indicators.
Follow machine operating instructions for disinfection period, extraction of hydrogen peroxide and re-entry. Prevent entry during disinfection process.
4.1.2. Use-specific risk mitigation measures
During operation, ensure adequate ventilation along the machines (LEV) and in the industrial halls (technical ventilation).
During manual maintenance tasks, ensure adequate ventilation inside the machine (LEV) before opening the doors of the aseptic area.
1. |
The product shall only be transferred in closed pipes after mixing and loading. Open product and waste water flows are not allowed. |
2. |
Workplace release measurements with suitable measurement equipment shall be performed upon implementation of the aseptic packaging plant, at regular intervals (annual intervals recommended) and after any change in relevant boundary conditions. The national regulations for workplace measurements have to be followed. |
3. |
In case of maintenance of the aseptic packaging plant (e.g. manual cleaning, technical incidents or repair) appropriate PPE (respiratory protective equipment, chemical protective gloves, chemical protective coverall (at least type 6), eye protection) is required. The type of RPE and the filter type (code letter, colour) are to be specified by the authorisation holder within the product information. Glove material to be specified by the authorisation holder within the product information |
Aerosolised or vaporised application should be use only in closed aseptic packaging machines with no emission to water and negligible emission to air. Hydrogen peroxide emission to air should be controlled by the machine e.g. with catalytic treatment or through a gas scrubber.
4.1.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
See general directions for use.
4.1.4. Where specific to the use, the instructions for safe disposal of the product and its packaging
See general directions for use.
4.1.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage
See general directions for use.
4.2. Use description
Table 8. Use # 2 – Disinfection of closed areas in aseptic packaging machines by aerosolised and vaporised hydrogen peroxide (VHP)
Product type |
PT04 - Food and feed area (Disinfectants) |
Where relevant, an exact description of the authorised use |
Not relevant |
Target organism(s) (including development stage) |
Common name: Bacterial Spores Development stage: |
Field(s) of use |
Indoor Industrial use - food and feed area. Disinfection of non-porous surfaces. |
Application method(s) |
Method: - Detailed description: Automated vaporisation or aerosolization in closed areas in aseptic filling machines. |
Application rate(s) and frequency |
Application Rate: Undiluted product (35 % w/w hydrogen peroxide) is used. 100 – 800 mL product consumed per machine in one disinfection cycle. Dilution (%): Number and timing of application: Frequency – as required by user, typically once every 24 hours. |
Category(ies) of users |
Professional |
Pack sizes and packaging material |
HDPE packaging: 0.25, 1, 2.5, 5, 10, 20, 22, 30, 60, 200, 220 and 1000 L (IBC). Approved grades of HDPE. |
4.2.1. Use-specific instructions for use
Use an automated loading system.
Automated disinfection of closed areas in aseptic filling machines.
Flash evaporation 130-250 °C or aerosolization (room temperature) of undiluted product using automated equipment integrated to the packaging machine. From 100 to 800 mL product required for one disinfection cycle. Minimum contact time 7 minutes starting from beginning of application.
Disinfection performance of each packaging machine should be validated using biological and chemical indicators.
Follow machine operating instructions for disinfection period, volume of disinfectant extraction of hydrogen peroxide and re-entry. Prevent entry during disinfection process.
4.2.2. Use-specific risk mitigation measures
During operation, ensure adequate ventilation along the machines (LEV) and in the industrial halls (technical ventilation).
During manual maintenance tasks, ensure adequate ventilation inside the machine (LEV) before opening the doors of the aseptic area.
1. |
The product shall only be transferred in closed pipes after mixing and loading. Open product and waste water flows are not allowed. |
2. |
Workplace release measurements with suitable measurement equipment shall be performed upon implementation of the aseptic packaging plant, at regular intervals (annual intervals recommended) and after any change in relevant boundary conditions. The national regulations for workplace measurements have to be followed. |
3. |
In case of maintenance of the aseptic packaging plant (e.g. manual cleaning, technical incidents or repair) appropriate PPE (respiratory protective equipment, chemical protective gloves, chemical protective coverall (at least type 6), eye protection) is required. The type of RPE and the filter type (code letter, colour) are to be specified by the authorisation holder within the product information. Glove material to be specified by the authorisation holder within the product information. |
Use only in closed aseptic packaging machines with no emission to water and negligible emission to air. Hydrogen peroxide emission to air should be controlled by the machine e.g. with catalytic treatment or through a gas scrubber.
4.2.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
See general directions for use.
4.2.4. Where specific to the use, the instructions for safe disposal of the product and its packaging
See general directions for use.
4.2.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage
See general directions for use.
5. GENERAL DIRECTIONS FOR USE (5) OF THE META SPC 5
5.1. Instructions for use
-
5.2. Risk mitigation measures
The use of eye protection during handling of the product is mandatory.
Wear face shield where splashing is possible.
5.3. Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
Particulars of likely direct or indirect adverse effects:
— |
In case of inhalation: Breathing difficulties, cough, pulmonary oedema, nausea, vomiting. |
— |
In case of skin contact: Redness, swelling of tissue, skin irritation. |
— |
In case of eye contact: Redness, lachrymation, swelling of tissue, severe burns. |
— |
In case of ingestion: Nausea, abdominal pain, bloody vomiting, diarrhoea, suffocation, cough, severe shortness of breath, severe burns of the mouth and throat, as well as a danger of perforation of the oesophagus and the stomach. Risk of respiratory disorder. |
First aid instructions:
|
IF INHALED: Move to fresh air and keep at rest in a position comfortable for breathing. If symptoms: Call 112/ambulance for medical assistance. If no symptoms: Call a POISON CENTRE or a doctor. |
|
IF ON SKIN: Immediately wash skin with plenty of water. Thereafter take off all contaminated clothing and wash it before reuse. Continue to wash the skin with water for 15 minutes. Call a POISON CENTRE or a doctor. |
|
IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing for at least 15 minutes. Call 112/ambulance for medical assistance. |
|
IF SWALLOWED: Immediately rinse mouth. Give something to drink, if exposed person is able to swallow. Do NOT induce vomiting. Call 112/ambulance for medical assistance. |
Emergency measures to protect environment in case of accident:
— |
Environmental precautions: Should not be released into the environment. If the product contaminates rivers and lakes or drains inform respective authorities. |
— |
Methods and materials for containment and cleaning up: Dilute with plenty of water. Dam up. Do not mix waste streams during collection. Soak up with inert absorbent material. Keep in properly labelled containers. Keep in suitable, closed containers for disposal. Never return spills in original containers for re-use. |
5.4. Instructions for safe disposal of the product and its packaging
Do not allow undiluted product to enter the sewer. Do not discharge unused product on the ground, into water courses, into pipes (sink, toilets…) nor down the drains. Only pass on empty containers/packaging for recycling. Disposal of packaging should at all times comply with the waste disposal legislation and any regional local authority requirements.
5.5. Conditions of storage and shelf-life of the product under normal conditions of storage
Storage: Hydrogen peroxide should be stored in properly designed bulk storage tanks or in original vented container in upright position away from incompatible products. Use only approved materials of construction for equipment or approved packs. Store in a cool, ventilated area and protect from damage and direct sunlight. Do not store at temperatures above 40°C. Keep away from combustible materials and sources of ignition and heat.
Shelf-life: 12 months in HDPE packs at ambient temperature.
6. OTHER INFORMATION
Please be aware of the European reference value of 1.25 mg/m3 for the active substance hydrogen peroxide (CAS No.: 7722-84-1) which was used for the risk assessment for this product.
7. THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 5
7.1. Trade name(s), authorisation number and specific composition of each individual product
Trade name(s) |
INTEROX AG Spray 35 |
Market area: EU |
||||
Authorisation number |
EU-0027468-0007 1-5 |
|||||
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
35,7 |
7.2. Trade name(s), authorisation number and specific composition of each individual product
Trade name(s) |
INTEROX AG Spray 35S |
Market area: EU |
||||
Authorisation number |
EU-0027468-0008 1-5 |
|||||
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
35,7 |
7.3. Trade name(s), authorisation number and specific composition of each individual product
Trade name(s) |
INTEROX AG Bath 35S |
Market area: EU |
||||
Authorisation number |
EU-0027468-0009 1-5 |
|||||
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
35,7 |
7.4. Trade name(s), authorisation number and specific composition of each individual product
Trade name(s) |
INTEROX AG Bath 35 |
Market area: EU |
||||
Authorisation number |
EU-0027468-0010 1-5 |
|||||
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
35,7 |
7.5. Trade name(s), authorisation number and specific composition of each individual product
Trade name(s) |
INTEROX AG Dual 35 |
Market area: EU |
||||
Authorisation number |
EU-0027468-0011 1-5 |
|||||
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
35,7 |
META SPC 6
1. META SPC 6 ADMINISTRATIVE INFORMATION
1.1. Meta SPC 6 identifier
Identifier |
Meta SPC 6 |
1.2. Suffix to the authorisation number
Number |
1-6 |
1.3. Product type(s)
Product type(s) |
PT04 - Food and feed area (Disinfectants) |
2. META SPC 6 COMPOSITION
2.1. Qualitative and quantitative information on the composition of the meta SPC 6
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Min |
Max |
|||||
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
35,0 |
35,7 |
2.2. Type(s) of formulation of the meta SPC 6
Formulation(s) |
SL - Soluble concentrate |
3. HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 6
Hazard statements |
May intensify fire; oxidiser Harmful if swallowed. Causes skin irritation. Causes serious eye damage. May cause respiratory irritation. Harmful to aquatic life with long lasting effects. |
Precautionary statements |
Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. - No smoking. Keep away from clothing and other combustible materials. Avoid breathing vapours. Wash hands thoroughly after handling. Do no eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Avoid release to the environment. Wear protective gloves. Wear protective clothing. Wear eye protection. Wear face protection. IF SWALLOWED:Call a POISON CENTER/doctor if you feel unwell. IF ON SKIN:Wash with plenty of water. IF INHALED:Remove person to fresh air and keep comfortable for breathing. IF IN EYES:Rinse cautiously with water for several minutes.Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor. Rinse mouth. If skin irritation occurs:Get medical advice. If skin irritation occurs:Get medical attention. Take off contaminated clothing.And wash it before reuse. In case of fire:Use water to extinguish. Store in a well-ventilated place.Keep container tightly closed. Store locked up. Dispose of contents to ….in accordance with all local, regional, national and international regulations.. Dispose of container to in accordance with local/regional/national/international regulation. |
4. AUTHORISED USE(S) OF THE META SPC 6
4.1. Use description
Table 9. Use # 1 – Disinfection of distribution and storage systems for drinking water
Product type |
PT04 - Food and feed area (Disinfectants) |
Where relevant, an exact description of the authorised use |
Not relevant |
Target organism(s) (including development stage) |
Common name: Bacteria Development stage: Common name: Fungi/yeasts Development stage: Common name: Viruses Development stage: Common name: Bacterial Spores Development stage: |
Field(s) of use |
Indoor Industrial use - drinking water systems for human and animals drinking water. Disinfection of non-porous surfaces. |
Application method(s) |
Method: - Detailed description: Flooding of pipes Automated spraying (CIP) |
Application rate(s) and frequency |
Application Rate: Use concentration 13% w/w hydrogen peroxide. Dilution (%): Number and timing of application: Apply at room temperature. Frequency: once per week. Use following installation, maintenance or cleaning. |
Category(ies) of users |
Professional |
Pack sizes and packaging material |
HDPE packaging: 0.25, 1, 2.5, 5, 10, 20, 22, 30, 60, 200, 220 and 1000 L (IBC). Approved grades of HDPE. |
4.1.1. Use-specific instructions for use
Use an automated loading system.
Dilute the product to reach the needed hydrogen peroxide concentration stated below.
Effective hydrogen peroxide (w/w) concentration and contact time:
|
Bactericidal – 13%, 10 min |
|
Yeasticidal and fungicidal – 13%, 15 min |
|
Sporicidal – 13 %, 60 min |
|
Virucidal – 13%, 30 min |
|
All claimed microbes - 13%, 60 min |
Each product label should give information on how the dilution should be made, e.g. to reach 13% (w/w) hydrogen peroxide concentration:
A product with 35 % hydrogen peroxide concentration: The product should be diluted to 39% w/v (390 g or 340 mL of product, add water up to 1L).
Apply diluted product at room temperature on pre-cleaned surfaces. Add as aqueous solution to pipes as needed for flooding. Spray application to tanks until run-off. Surface need to be wet with disinfectant for the allocated contact time.
4.1.2. Use-specific risk mitigation measures
CIP and automated spraying:
The processes must be fully automated and enclosed with no exposure in the case of tanks or piping systems.
The use is limited to distribution and storage systems with volume ≤ 15 000 L. Rinse well with potable water.
4.1.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
See general directions for use.
4.1.4. Where specific to the use, the instructions for safe disposal of the product and its packaging
See general directions for use.
4.1.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage
See general directions for use.
4.2. Use description
Table 10. Use # 2 – Surface disinfection in food and feed processing by liquid application
Product type |
PT04 - Food and feed area (Disinfectants) |
||||||
Where relevant, an exact description of the authorised use |
Disinfection of equipment, containers, consumption utensils, surfaces or pipework associated with the production, transport, storage or consumption of food or feed for humans and animals. |
||||||
Target organism(s) (including development stage) |
Common name: Bacteria Development stage: Common name: Fungi/yeasts Development stage: Common name: Viruses Development stage: Common name: Bacterial Spores Development stage: |
||||||
Field(s) of use |
Indoor Industrial use - food & feed area. Disinfection of non-porous surfaces. |
||||||
Application method(s) |
Method: - Detailed description: Automated spraying on surfaces Cleaning-in-Place (CIP) Immersion of equipment and utensils |
||||||
Application rate(s) and frequency |
Application Rate: Use concentration 13% w/w hydrogen peroxide. Dilution (%): Number and timing of application:
As required by user - up to 1 or 2 times per day, often once per week. Apply at room temperature. |
||||||
Category(ies) of users |
Professional |
||||||
Pack sizes and packaging material |
HDPE packaging: 0.25, 1, 2.5, 5, 10, 20, 22, 30, 60, 200, 220 and 1000 L (IBC). Approved grades of HDPE. |
4.2.1. Use-specific instructions for use
Disinfection of pre-cleaned, non-porous surfaces such as tables, floors, walls, machinery, equipment and utensils in food & feed areas in production, transport, storage or preparation and handling. CIP (cleaning in place) disinfection (terminal disinfection after cleaning) – pipes, tanks, mixer, other machine which comes into contact with food. Soaking of pre-cleaned items – dishes, cutlery, equipment, small machinery, machine items, crates, boxes.
Use an automated loading system for CIP and automated spraying.
Dilute the product to reach the needed hydrogen peroxide concentration stated below.
Effective hydrogen peroxide (w/w) concentration and contact time:
|
Bactericidal, yeasticidal, fungicidal – 13%, 15 min |
|
Sporicidal – 13 %, 60 min |
|
Virucidal – 13%, 30 min |
|
All claimed microbes - 13%, 60 min |
Each product label should give information on how the dilution should be made, e.g. to reach 13% (w/w) hydrogen peroxide concentration:
A product with 35% hydrogen peroxide concentration: The product should be diluted to 39% w/v (390 g or 340 mL of product, add water up to 1L).
Apply at room temperature.
Precleaning of surfaces required before using disinfectants.
Dosing
— Automated spraying 50 – 100 mL/m2
Surface need to be wet with disinfectant for the allocated contact time. Rinse well with potable water and allow to drain or dry with hot air.
4.2.2. Use-specific risk mitigation measures
CIP:
The processes must be fully automated and enclosed with no exposure in the case of tanks or piping systems.
Automated spraying:
In the case of automated spraying of surfaces such as conveyors or other fixed installations workers must leave the room before processing.
Disinfection can only be processed after the end of a shift with all workers having left the room. The process must be started from outside the room. Warning notices indicating that entry is denied and temporary barriers must be placed on all entries.
Air concentrations must be monitored to ensure that no leakage occurs during operations. For re-entry, the undercut of AECinhalation of 1.25 mg/m3 shall be ensured with technical and organisational measures (e.g. sensor, defined ventilation period).
Immersion:
The use of eye protection during handling of the product is mandatory.
Wear protective chemical resistant gloves during product handling phase (glove material to be specified by the authorisation holder within the product information).
A protective coverall (at least type 6, EN 13034) shall be worn in loading.
For stationary processes, a local exhaust ventilation (LEV) with a capture efficiency of at least 85% shall be specified.
If no LEV, use respiratory protective equipment (RPE) providing a protection factor of 20 in loading and 5 for immersion.
After use, immersion baths must be emptied or covered to prevent further evaporation.
The waste water from breweries should not be discharged direct to surface water after simple on-site treatment. The waste water from breweries should be discharged to the sewer connected to the sewage treatment plant (STP).
4.2.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
See general directions for use.
4.2.4. Where specific to the use, the instructions for safe disposal of the product and its packaging
See general directions for use.
4.2.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage
See general directions for use.
5. GENERAL DIRECTIONS FOR USE (6) OF THE META SPC 6
5.1. Instructions for use
-
5.2. Risk mitigation measures
The use of eye protection during handling of the product is mandatory.
Wear face shield where splashing is possible.
Ensure adequate ventilation during the application.
5.3. Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
Particulars of likely direct or indirect adverse effects:
— |
In case of inhalation: Breathing difficulties, cough, pulmonary oedema, nausea, vomiting. |
— |
In case of skin contact: Redness, swelling of tissue, skin irritation. |
— |
In case of eye contact: Redness, lachrymation, swelling of tissue, severe burns. |
— |
In case of ingestion: Nausea, abdominal pain, bloody vomiting, diarrhoea, suffocation, cough, severe shortness of breath, severe burns of the mouth and throat, as well as a danger of perforation of the oesophagus and the stomach. Risk of respiratory disorder. |
First aid instructions:
|
IF INHALED: Move to fresh air and keep at rest in a position comfortable for breathing. If symptoms: Call 112/ambulance for medical assistance. If no symptoms: Call a POISON CENTRE or a doctor. |
|
IF ON SKIN: Immediately wash skin with plenty of water. Thereafter take off all contaminated clothing and wash it before reuse. Continue to wash the skin with water for 15 minutes. Call a POISON CENTRE or a doctor. |
|
IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing for at least 15 minutes. Call 112/ambulance for medical assistance. |
|
IF SWALLOWED: Immediately rinse mouth. Give something to drink, if exposed person is able to swallow. Do NOT induce vomiting. Call 112/ambulance for medical assistance. |
Emergency measures to protect environment in case of accident:
— |
Environmental precautions: Should not be released into the environment. If the product contaminates rivers and lakes or drains inform respective authorities. |
— |
Methods and materials for containment and cleaning up: Dilute with plenty of water. Dam up. Do not mix waste streams during collection. Soak up with inert absorbent material. Keep in properly labelled containers. Keep in suitable, closed containers for disposal. Never return spills in original containers for re-use. |
5.4. Instructions for safe disposal of the product and its packaging
Do not allow undiluted product to enter the sewer. Do not discharge unused product on the ground, into water courses, into pipes (sink, toilets…) nor down the drains. Only pass on empty containers/packaging for recycling. Disposal of packaging should at all times comply with the waste disposal legislation and any regional local authority requirements.
5.5. Conditions of storage and shelf-life of the product under normal conditions of storage
Storage: Hydrogen peroxide should be stored in properly designed bulk storage tanks or in original vented container in upright position away from incompatible products. Use only approved materials of construction for equipment or approved packs. Store in a cool, ventilated area and protect from damage and direct sunlight. Do not store at temperatures above 40°C. Keep away from combustible materials and sources of ignition and heat.
Shelf-life: 12 months in HDPE packs at ambient temperature.
6. OTHER INFORMATION
Please be aware of the European reference value of 1.25 mg/m3 for the active substance hydrogen peroxide (CAS No.: 7722-84-1) which was used for the risk assessment for this product.
7. THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 6
7.1. Trade name(s), authorisation number and specific composition of each individual product
Trade name(s) |
INTEROX FCC 35 |
Market area: EU |
||||
Authorisation number |
EU-0027468-0012 1-6 |
|||||
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
35,7 |
META SPC 7
1. META SPC 7 ADMINISTRATIVE INFORMATION
1.1. Meta SPC 7 identifier
Identifier |
Meta SPC 7 |
1.2. Suffix to the authorisation number
Number |
1-7 |
1.3. Product type(s)
Product type(s) |
PT04 - Food and feed area (Disinfectants) |
2. META SPC 7 COMPOSITION
2.1. Qualitative and quantitative information on the composition of the meta SPC 7
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Min |
Max |
|||||
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
49,0 |
49,9 |
2.2. Type(s) of formulation of the meta SPC 7
Formulation(s) |
SL - Soluble concentrate |
3. HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 7
Hazard statements |
May intensify fire; oxidiser Harmful if swallowed. Causes severe skin burns and eye damage. May cause respiratory irritation. Harmful to aquatic life with long lasting effects. |
Precautionary statements |
Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. - No smoking. Keep away from clothing and other combustible materials. Do not breathe vapours. Wash hands thoroughly after handling. Do no eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Avoid release to the environment. Wear protective gloves. Wear protective clothing. Wear eye protection. Wear face protection. IF SWALLOWED:Call a POISON CENTER/doctor if you feel unwell. IF SWALLOWED:Rinse mouth.Do NOT induce vomiting. IF ON SKIN (or hair):Take off immediately all contaminated clothing.Rinse skin with water. IF INHALED:Remove person to fresh air and keep comfortable for breathing. IF IN EYES:Rinse cautiously with water for several minutes.Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor. Wash contaminated clothing before reuse. In case of fire:Use water to extinguish. Store in a well-ventilated place.Keep container tightly closed. Store locked up. Dispose of contents to ….in accordance with all local, regional, national and international regulations.. Dispose of container to in accordance with local/regional/national/international regulation. |
4. AUTHORISED USE(S) OF THE META SPC 7
4.1. Use description
Table 11. Use # 1 – Disinfection of distribution and storage systems for drinking water
Product type |
PT04 - Food and feed area (Disinfectants) |
Where relevant, an exact description of the authorised use |
Not relevant |
Target organism(s) (including development stage) |
Common name: Bacteria Development stage: Common name: Fungi/yeasts Development stage: Common name: Viruses Development stage: Common name: Bacterial Spores Development stage: |
Field(s) of use |
Indoor Industrial use - drinking water systems for human and animals drinking water. Disinfection of non-porous surfaces. |
Application method(s) |
Method: - Detailed description: Flooding of pipes Automated spraying (CIP) |
Application rate(s) and frequency |
Application Rate: Use concentration 13% w/w hydrogen peroxide. Dilution (%): Number and timing of application: Apply at room temperature. Frequency: once per week. Use following installation, maintenance or cleaning. |
Category(ies) of users |
Professional |
Pack sizes and packaging material |
HDPE packaging: 0.25, 1, 2.5, 5, 10, 20, 22, 30, 60, 200, 220 and 1000 L (IBC). Approved grades of HDPE. |
4.1.1. Use-specific instructions for use
Use an automated loading system.
Dilute the product to reach the needed hydrogen peroxide concentration stated below.
Effective hydrogen peroxide (w/w) concentration and contact time:
|
Bactericidal – 13%, 10 min |
|
Yeasticidal and fungicidal – 13%, 15 min |
|
Sporicidal – 13 %, 60 min |
|
Virucidal – 13%, 30 min |
|
All claimed microbes - 13%, 60 min |
Each product label should give information on how the dilution should be made, e.g. to reach 13% (w/w) hydrogen peroxide concentration:
A product with 50% hydrogen peroxide concentration: The product should be diluted to 28% w/v (280 g or 230 mL of product, add water up to 1L).
Apply diluted product at room temperature on pre-cleaned surfaces. Add as aqueous solution to pipes as needed for flooding. Spray application to tanks until run-off. Surface need to be wet with disinfectant for the allocated contact time.
4.1.2. Use-specific risk mitigation measures
CIP and automated spraying:
The processes must be fully automated and enclosed with no exposure in the case of tanks or piping systems.
The use is limited to distribution and storage systems with volume ≤ 15 000 L. Rinse well with potable water.
4.1.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
See general directions for use.
4.1.4. Where specific to the use, the instructions for safe disposal of the product and its packaging
See general directions for use.
4.1.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage
See general directions for use.
4.2. Use description
Table 12. Use # 2 – Surface disinfection in food and feed processing by liquid application
Product type |
PT04 - Food and feed area (Disinfectants) |
||||||
Where relevant, an exact description of the authorised use |
Disinfection of equipment, containers, consumption utensils, surfaces or pipework associated with the production, transport, storage or consumption of food or feed for humans and animals. |
||||||
Target organism(s) (including development stage) |
Common name: Bacteria Development stage: Common name: Fungi/yeasts Development stage: Common name: Viruses Development stage: Common name: Bacterial Spores Development stage: |
||||||
Field(s) of use |
Indoor Industrial use - food & feed area. Disinfection of non-porous surfaces. |
||||||
Application method(s) |
Method: - Detailed description: Automated spraying on surfaces Cleaning-in-Place (CIP) Immersion of equipment and utensils |
||||||
Application rate(s) and frequency |
Application Rate: Use concentration 13% w/w hydrogen peroxide. Dilution (%): Number and timing of application:
As required by user - up to 1 or 2 times per day, often once per week. Apply at room temperature. |
||||||
Category(ies) of users |
Professional |
||||||
Pack sizes and packaging material |
HDPE packaging: 0.25, 1, 2.5, 5, 10, 20, 22, 30, 60, 200, 220 and 1000 L (IBC). Approved grades of HDPE. |
4.2.1. Use-specific instructions for use
Disinfection of pre-cleaned, non-porous surfaces such as tables, floors, walls, machinery, equipment and utensils in food & feed areas in production, transport, storage or preparation and handling. CIP (cleaning in place) disinfection (terminal disinfection after cleaning) – pipes, tanks, mixer, other machine which comes into contact with food. Soaking of pre-cleaned items – dishes, cutlery, equipment, small machinery, machine items, crates, boxes.
Use an automated loading system for CIP and automated spraying.
Dilute the product to reach the needed hydrogen peroxide concentration stated below.
Effective hydrogen peroxide (w/w) concentration and contact time:
|
Bactericidal, yeasticidal, fungicidal – 13%, 15 min |
|
Sporicidal – 13%, 60 min |
|
Virucidal – 13%, 30 min |
|
All claimed microbes - 13%, 60 min |
Each product label should give information on how the dilution should be made, e.g. to reach 13% (w/w) hydrogen peroxide concentration:
A product with 50% hydrogen peroxide concentration: The product should be diluted to 28% w/v (280 g or 230 mL of product, add water up to 1L).
Apply at room temperature.
Precleaning of surfaces required before using disinfectants.
Dosing
— Automated spraying 50 – 100 mL/m2
Surface need to be wet with disinfectant for the allocated contact time.
Rinse well with potable water and allow to drain or dry with hot air.
4.2.2. Use-specific risk mitigation measures
CIP:
The processes must be fully automated and enclosed with no exposure in the case of tanks or piping systems.
Automated spraying:
In the case of automated spraying of surfaces such as conveyors or other fixed installations workers must leave the room before processing.
Disinfection can only be processed after the end of a shift with all workers having left the room. The process must be started from outside the room. Warning notices indicating that entry is denied and temporary barriers must be placed on all entries.
Air concentrations must be monitored to ensure that no leakage occurs during operations and levels are safe before entering the area. For re-entry, the undercut of AECinhalation of 1.25 mg/m3 shall be ensured with technical and organisational measures (e.g. sensor, defined ventilation period).
Immersion:
The use of eye protection during handling of the product is mandatory.
Wear protective chemical resistant gloves during product handling phase (glove material to be specified by the authorisation holder within the product information).
A protective coverall (at least type 6, EN 13034) shall be worn in loading.
For stationary processes, a local exhaust ventilation (LEV) with a capture efficiency of at least 85% shall be specified.
If no LEV, use respiratory protective equipment (RPE) providing a protection factor of 20 in loading and 5 for immersion.
After use, immersion baths must be emptied or covered to prevent further evaporation.
The waste water from breweries should not be discharged direct to surface water after simple on-site treatment. The waste water from breweries should be discharged to the sewer connected to the sewage treatment plant (STP).
4.2.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
See general directions for use.
4.2.4. Where specific to the use, the instructions for safe disposal of the product and its packaging
See general directions for use.
4.2.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage
See general directions for use.
5. GENERAL DIRECTIONS FOR USE (7) OF THE META SPC 7
5.1. Instructions for use
-
5.2. Risk mitigation measures
The use of eye protection during handling of the product is mandatory.
Wear face shield where splashing is possible.
Ensure adequate ventilation during the application.
5.3. Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
Particulars of likely direct or indirect adverse effects:
— |
In case of inhalation: Breathing difficulties, cough, pulmonary oedema, nausea, vomiting. |
— |
In case of skin contact: Redness, swelling of tissue, skin irritation. |
— |
In case of eye contact: Redness, lachrymation, swelling of tissue, severe burns. |
— |
In case of ingestion: Nausea, abdominal pain, bloody vomiting, diarrhoea, suffocation, cough, severe shortness of breath, severe burns of the mouth and throat, as well as a danger of perforation of the oesophagus and the stomach. Risk of respiratory disorder. |
First aid instructions:
|
IF INHALED: Move to fresh air and keep at rest in a position comfortable for breathing. If symptoms: Call 112/ambulance for medical assistance. If no symptoms: Call a POISON CENTRE or a doctor. |
|
IF ON SKIN: Immediately wash skin with plenty of water. Thereafter take off all contaminated clothing and wash it before reuse. Continue to wash the skin with water for 15 minutes. Call a POISON CENTRE or a doctor. |
|
IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing for at least 15 minutes. Call 112/ambulance for medical assistance. |
|
IF SWALLOWED: Immediately rinse mouth. Give something to drink, if exposed person is able to swallow. Do NOT induce vomiting. Call 112/ambulance for medical assistance. |
Emergency measures to protect environment in case of accident:
— |
Environmental precautions: Should not be released into the environment. If the product contaminates rivers and lakes or drains inform respective authorities. |
— |
Methods and materials for containment and cleaning up: Dilute with plenty of water. Dam up. Do not mix waste streams during collection. Soak up with inert absorbent material. Keep in properly labelled containers. Keep in suitable, closed containers for disposal. Never return spills in original containers for re-use. |
5.4. Instructions for safe disposal of the product and its packaging
Do not allow undiluted product to enter the sewer. Do not discharge unused product on the ground, into water courses, into pipes (sink, toilets…) nor down the drains. Only pass on empty containers/packaging for recycling. Disposal of packaging should at all times comply with the waste disposal legislation and any regional local authority requirements.
5.5. Conditions of storage and shelf-life of the product under normal conditions of storage
Storage: Hydrogen peroxide should be stored in properly designed bulk storage tanks or in original vented container in upright position away from incompatible products. Use only approved materials of construction for equipment or approved packs. Store in a cool, ventilated area and protect from damage and direct sunlight. Do not store at temperatures above 40°C. Keep away from combustible materials and sources of ignition and heat.
Shelf-life: 12 months in HDPE packs at ambient temperature.
6. OTHER INFORMATION
Please be aware of the European reference value of 1.25 mg/m3 for the active substance hydrogen peroxide (CAS No.: 7722-84-1) which was used for the risk assessment for this product.
7. THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 7
7.1. Trade name(s), authorisation number and specific composition of each individual product
Trade name(s) |
INTEROX FCC 50 |
Market area: EU |
||||
Authorisation number |
EU-0027468-0013 1-7 |
|||||
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
49,9 |
META SPC 8
1. META SPC 8 ADMINISTRATIVE INFORMATION
1.1. Meta SPC 8 identifier
Identifier |
Meta SPC 8 |
1.2. Suffix to the authorisation number
Number |
1-8 |
1.3. Product type(s)
Product type(s) |
PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) PT03 - Veterinary hygiene (Disinfectants) |
2. META SPC 8 COMPOSITION
2.1. Qualitative and quantitative information on the composition of the meta SPC 8
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Min |
Max |
|||||
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
35,0 |
35,7 |
2.2. Type(s) of formulation of the meta SPC 8
Formulation(s) |
SL - Soluble concentrate |
3. HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 8
Hazard statements |
May intensify fire; oxidiser Harmful if swallowed. Causes skin irritation. Causes serious eye damage. May cause respiratory irritation. Harmful to aquatic life with long lasting effects. |
Precautionary statements |
Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. - No smoking. Keep away from clothing and other combustible materials. Avoid breathing vapours. Avoid breathing spray. Wash hands thoroughly after handling. Do no eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Avoid release to the environment. Wear protective gloves. Wear protective clothing. Wear eye protection. Wear face protection. IF SWALLOWED:Call a POISON CENTER/doctor if you feel unwell. IF ON SKIN:Wash with plenty of water. IF INHALED:Remove person to fresh air and keep comfortable for breathing. IF IN EYES:Rinse cautiously with water for several minutes.Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor. Rinse mouth. If skin irritation occurs:Get medical advice. If skin irritation occurs:Get medical attention. Take off contaminated clothing.And wash it before reuse. In case of fire:Use water to extinguish. Store in a well-ventilated place.Keep container tightly closed. Store locked up. Dispose of contents to ….in accordance with all local, regional, national and international regulations.. Dispose of container to in accordance with local/regional/national/international regulation. |
4. AUTHORISED USE(S) OF THE META SPC 8
4.1. Use description
Table 13. Use # 1 – Surface disinfection by liquid application in industrial and institutional areas
Product type |
PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) |
||||||
Where relevant, an exact description of the authorised use |
Not relevant |
||||||
Target organism(s) (including development stage) |
Common name: Bacteria Development stage: Common name: Fungi/yeasts Development stage: Common name: Viruses Development stage: Common name: Bacterial spores Development stage: |
||||||
Field(s) of use |
Indoor Industrial or institutional use. Disinfection of non-porous surfaces. |
||||||
Application method(s) |
Method: - Detailed description: Automated spraying on surfaces Cleaning-in-Place (CIP) Immersion of equipment and utensils |
||||||
Application rate(s) and frequency |
Application Rate: Use concentration 13% w/w hydrogen peroxide. Dilution (%): Number and timing of application:
Frequency - as required by the user. Apply at room temperature. |
||||||
Category(ies) of users |
Professional |
||||||
Pack sizes and packaging material |
HDPE packaging: 0.25, 1, 2.5, 5, 10, 20, 22, 30, 60, 200, 220 and 1000 L (IBC). Approved grades of HDPE. |
4.1.1. Use-specific instructions for use
Use an automated loading system for CIP and automated spraying.
Dilute the product to reach the needed hydrogen peroxide concentration stated below.
Effective hydrogen peroxide concentration (w/w) and contact time:
|
Bactericidal - 13 %, 10 min |
|
Sporicidal – 13%, 60 min |
|
Yeasticidal and fungicidal – 13%, 15 min |
|
Virucidal – 13%, 30 min |
|
All claimed microbes - 13%, 60 min |
Each product label should give information on how the dilution should be made, e.g. to reach 13% (w/w) hydrogen peroxide concentration:
A product with 35% hydrogen peroxide concentration: The product should be diluted to 39% w/v (390 g or 340 mL of product, add water up to 1L).
Precleaning of surfaces required before using disinfectants.
Automated spraying of diluted product 50 -100 mL /m2 on non-porous surfaces. Surface needs to stay wet for the allocated contact time.
Immerse instruments in diluted product for the allocated contact time. Allow to drain and dry.
4.1.2. Use-specific risk mitigation measures
CIP:
The processes must be fully automated and enclosed with no exposure in the case of tanks or piping systems.
Automated spraying:
In the case of automated spraying of surfaces such as conveyors or other fixed installations workers must leave the room before processing.
Disinfection can only be processed after the end of a shift with all workers having left the room. The process must be started from outside the room. Warning notices indicating that entry is denied and temporary barriers must be placed on all entries.
Air concentrations must be monitored to ensure that no leakage occurs during operations. For re-entry, the undercut of AECinhalation of 1.25 mg/m3 shall be ensured with technical and organisational measures (e.g. sensor, defined ventilation period).
Immersion:
The use of eye protection during handling of the product is mandatory.
Wear protective chemical resistant gloves during product handling phase (glove material to be specified by the authorisation holder within the product information).
A protective coverall (at least type 6, EN 13034) shall be worn in loading.
For stationary processes, a local exhaust ventilation (LEV) with a capture efficiency of at least 85% shall be specified.
If no LEV, use respiratory protective equipment (RPE) providing a protection factor of 20 in loading and 5 for immersion.
After use, immersion baths must be emptied or covered to prevent further evaporation.
4.1.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
See general directions for use.
4.1.4. Where specific to the use, the instructions for safe disposal of the product and its packaging
See general directions for use.
4.1.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage
See general directions for use.
4.2. Use description
Table 14. Use # 2 – Disinfection of surfaces associated with animal housing by spraying
Product type |
PT03 - Veterinary hygiene (Disinfectants) |
Where relevant, an exact description of the authorised use |
Not relevant |
Target organism(s) (including development stage) |
Common name: Bacteria Development stage: Common name: Fungi/yeasts Development stage: Common name: Viruses Development stage: |
Field(s) of use |
Indoor Disinfection of non-porous materials and surfaces associated with the housing of animals. |
Application method(s) |
Method: - Detailed description: Spraying with automated or manual equipment |
Application rate(s) and frequency |
Application Rate: Use concentration 9.5-13 % w/w hydrogen peroxide. Dilution (%): Number and timing of application: Spraying: 50 -100 mL diluted product/m2. Frequency depends on life-cycle of animals - as required by user. |
Category(ies) of users |
Professional |
Pack sizes and packaging material |
HDPE packaging: 0.25, 1, 2.5, 5, 10, 20, 22, 30, 60, 200, 220 and 1000 L (IBC). Approved grades of HDPE. |
4.2.1. Use-specific instructions for use
Dilute the product to reach the needed hydrogen peroxide concentration stated below.
Effective hydrogen peroxide concentration (w/w) and contact time:
|
Bactericidal and yeasticidal - 9.5%, 30 min |
|
Fungicidal – 13%, 60 min |
|
Virucidal – 13%, 30 min |
|
All claimed microbes - 13%, 60 min |
Each product label should give information on how the dilution should be made, e.g. to reach 13% (w/w) hydrogen peroxide concentration:
A product with 35% hydrogen peroxide concentration: The product should be diluted to 39% w/v (390 g or 340 mL of product, add water up to 1L).
Remove animals from spaces to be disinfected. Precleaning of surfaces required before using disinfectants.
Spray diluted product 50 -100 mL /m2 on non-porous surfaces. Surface needs to stay wet for the allocated contact time. Allow to drain and dry.
4.2.2. Use-specific risk mitigation measures
Automated spraying systems:
During the operation worker must leave the area and access must be denied by appropriate barriers or locked doors. After operation efficient ventilation (10 ACH) must be used to reach a safe level. During this period access must also be denied. Air concentrations must be monitored to ensure that no leakage occurs during operations. For re-entry, the undercut of AECinhalation of 1.25 mg/m3 shall be ensured with technical and organisational measures (e.g. sensor, defined ventilation period).
For manual spraying:
The use of eye protection during handling of the product is mandatory.
Wear protective chemical resistant gloves during product handling phase (glove material to be specified by the authorisation holder within the product information).
A protective coverall (at least type 6, EN 13034) shall be worn.
Use of respiratory protective equipment (RPE) providing a protection factor of 10 is mandatory. At least a powered air purifying respirator with helmet/hood/mask (TH1/TM1), or a half/full mask with combination filter gas/P2 is required (filter type (code letter, colour) to be specified by the authorisation holder within the product information).
Only operators wearing the specified RPE should be present while spraying or fumigating.
The operator must walk backward towards the exit while spraying the surfaces so always walking away from sprayed areas.
Efficient ventilation (10 ACH) must be used during spraying and access must be denied by appropriate barriers and notices. Also after operation efficient ventilation (10 ACH) must be used to reach a safe level. During this period access must also be denied. Air concentrations must be monitored to ensure that no leakage occurs during operations. For re-entry, the undercut of AECinhalation of 1.25 mg/m3 shall be ensured with technical and organisational measures (e.g. sensor, defined ventilation period).
No secondary exposure is expected because of rapid decomposition of hydrogen peroxide.
4.2.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
See general directions for use.
4.2.4. Where specific to the use, the instructions for safe disposal of the product and its packaging
See general directions for use.
4.2.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage
See general directions for use.
5. GENERAL DIRECTIONS FOR USE (8) OF THE META SPC 8
5.1. Instructions for use
-
5.2. Risk mitigation measures
The use of eye protection during handling of the product is mandatory.
Wear face shield where splashing is possible.
Ensure adequate ventilation during the application.
5.3. Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
Particulars of likely direct or indirect adverse effects:
— |
In case of inhalation: Breathing difficulties, cough, pulmonary oedema, nausea, vomiting. |
— |
In case of skin contact: Redness, swelling of tissue, skin irritation. |
— |
In case of eye contact: Redness, lachrymation, swelling of tissue, severe burns. |
— |
In case of ingestion: Nausea, abdominal pain, bloody vomiting, diarrhoea, suffocation, cough, severe shortness of breath, severe burns of the mouth and throat, as well as a danger of perforation of the oesophagus and the stomach. Risk of respiratory disorder. |
First aid instructions:
|
IF INHALED: Move to fresh air and keep at rest in a position comfortable for breathing. If symptoms: Call 112/ambulance for medical assistance. If no symptoms: Call a POISON CENTRE or a doctor. |
|
IF ON SKIN: Immediately wash skin with plenty of water. Thereafter take off all contaminated clothing and wash it before reuse. Continue to wash the skin with water for 15 minutes. Call a POISON CENTRE or a doctor. |
|
IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing for at least 15 minutes. Call 112/ambulance for medical assistance. |
|
IF SWALLOWED: Immediately rinse mouth. Give something to drink, if exposed person is able to swallow. Do NOT induce vomiting. Call 112/ambulance for medical assistance. |
Emergency measures to protect environment in case of accident:
— |
Environmental precautions: Should not be released into the environment. If the product contaminates rivers and lakes or drains inform respective authorities. |
— |
Methods and materials for containment and cleaning up: Dilute with plenty of water. Dam up. Do not mix waste streams during collection. Soak up with inert absorbent material. Keep in properly labelled containers. Keep in suitable, closed containers for disposal. Never return spills in original containers for re-use. |
5.4. Instructions for safe disposal of the product and its packaging
Do not allow undiluted product to enter the sewer. Do not discharge unused product on the ground, into water courses, into pipes (sink, toilets…) nor down the drains. Only pass on empty containers/packaging for recycling. Disposal of packaging should at all times comply with the waste disposal legislation and any regional local authority requirements.
5.5. Conditions of storage and shelf-life of the product under normal conditions of storage
Storage: Hydrogen peroxide should be stored in properly designed bulk storage tanks or in original vented container in upright position away from incompatible products. Use only approved materials of construction for equipment or approved packs. Store in a cool, ventilated area and protect from damage and direct sunlight. Do not store at temperatures above 40°C. Keep away from combustible materials and sources of ignition and heat.
Shelf-life: 12 months in HDPE packs at ambient temperature.
6. OTHER INFORMATION
Please be aware of the European reference value of 1.25 mg/m3 for the active substance hydrogen peroxide (CAS No.: 7722-84-1) which was used for the risk assessment for this product.
7. THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 8
7.1. Trade name(s), authorisation number and specific composition of each individual product
Trade name(s) |
INTEROX BT 35 |
Market area: EU |
||||
Authorisation number |
EU-0027468-0014 1-8 |
|||||
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
35,7 |
META SPC 9
1. META SPC 9 ADMINISTRATIVE INFORMATION
1.1. Meta SPC 9 identifier
Identifier |
Meta SPC 9 |
1.2. Suffix to the authorisation number
Number |
1-9 |
1.3. Product type(s)
Product type(s) |
PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) PT03 - Veterinary hygiene (Disinfectants) |
2. META SPC 9 COMPOSITION
2.1. Qualitative and quantitative information on the composition of the meta SPC 9
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Min |
Max |
|||||
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
49,0 |
49,9 |
2.2. Type(s) of formulation of the meta SPC 9
Formulation(s) |
SL - Soluble concentrate |
3. HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 9
Hazard statements |
May intensify fire; oxidiser Harmful if swallowed. Causes severe skin burns and eye damage. May cause respiratory irritation. Harmful to aquatic life with long lasting effects. |
Precautionary statements |
Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. - No smoking. Keep away from clothing and other combustible materials. Do not breathe vapours. Do not breathe spray. Wash hands thoroughly after handling. Do no eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Avoid release to the environment. Wear protective gloves. Wear protective clothing. Wear eye protection. Wear face protection. IF SWALLOWED:Call a POISON CENTER/doctor if you feel unwell. IF SWALLOWED:Rinse mouth.Do NOT induce vomiting. IF ON SKIN (or hair):Take off immediately all contaminated clothing.Rinse skin with water. IF INHALED:Remove person to fresh air and keep comfortable for breathing. IF IN EYES:Rinse cautiously with water for several minutes.Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor. Wash contaminated clothing before reuse. In case of fire:Use water to extinguish. Store in a well-ventilated place.Keep container tightly closed. Store locked up. Dispose of contents to ….in accordance with all local, regional, national and international regulations.. Dispose of container to in accordance with local/regional/national/international regulation. |
4. AUTHORISED USE(S) OF THE META SPC 9
4.1. Use description
Table 15. Use # 1 – Surface disinfection by liquid application in industrial and institutional areas
Product type |
PT02 - Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) |
||||||
Where relevant, an exact description of the authorised use |
Not relevant |
||||||
Target organism(s) (including development stage) |
Common name: Bacteria Development stage: Common name: Fungi/yeasts Development stage: Common name: Viruses Development stage: Common name: Bacterial spores Development stage: |
||||||
Field(s) of use |
Indoor Industrial or institutional use. Disinfection of non-porous surfaces. |
||||||
Application method(s) |
Method: - Detailed description: Automated spraying on surfaces Cleaning-in-Place (CIP) Immersion of equipment and utensils |
||||||
Application rate(s) and frequency |
Application Rate: Use concentration 13% w/w hydrogen peroxide. Dilution (%): Number and timing of application:
Frequency - as required by the user. Apply at room temperature. |
||||||
Category(ies) of users |
Professional |
||||||
Pack sizes and packaging material |
HDPE packaging: 0.25, 1, 2.5, 5, 10, 20, 22, 30, 60, 200, 220 and 1000 L (IBC). Approved grades of HDPE. |
4.1.1. Use-specific instructions for use
Use an automated loading system for CIP and automated spraying.
Dilute the product to reach the needed hydrogen peroxide concentration stated below.
Effective hydrogen peroxide concentration (w/w) and contact time:
|
Bactericidal - 13%, 10 min |
|
Sporicidal – 13%, 60 min |
|
Yeasticidal and fungicidal – 13%, 15 min |
|
Virucidal – 13%, 30 min |
|
All claimed microbes - 13%, 60 min |
Each product label should give information on how the dilution should be made, e.g. to reach 13% (w/w) hydrogen peroxide concentration:
A product with 50% hydrogen peroxide concentration: The product should be diluted to 28% w/v (280 g or 230 mL of product, add water up to 1 L).
Precleaning of surfaces required before using disinfectants.
Automated spraying of diluted product 50 -100 mL /m2 on non-porous surfaces. Surface needs to stay wet for the allocated contact time.
Immerse instruments in diluted product for the allocated contact time. Allow to drain and dry.
4.1.2. Use-specific risk mitigation measures
CIP:
The processes must be fully automated and enclosed with no exposure in the case of tanks or piping systems.
Automated spraying:
In the case of automated spraying of surfaces such as conveyors or other fixed installations workers must leave the room before processing.
Disinfection can only be processed after the end of a shift with all workers having left the room. The process must be started from outside the room. Warning notices indicating that entry is denied and temporary barriers must be placed on all entries.
Air concentrations must be monitored to ensure that no leakage occurs during operations. For re-entry, the undercut of AECinhalation of 1.25 mg/m3 shall be ensured with technical and organisational measures (e.g. sensor, defined ventilation period).
Immersion:
The use of eye protection during handling of the product is mandatory.
Wear protective chemical resistant gloves during product handling phase (glove material to be specified by the authorisation holder within the product information).
A protective coverall (at least type 6, EN 13034) shall be worn in loading.
For stationary processes, a local exhaust ventilation (LEV) with a capture efficiency of at least 85% shall be specified.
If no LEV, use respiratory protective equipment (RPE) providing a protection factor of 20 in loading and 5 for immersion.
After use, immersion baths must be emptied or covered to prevent further evaporation.
4.1.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
See general directions for use
4.1.4. Where specific to the use, the instructions for safe disposal of the product and its packaging
See general directions for use.
4.1.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage
See general directions for use.
4.2. Use description
Table 16. Use # 2 – Disinfection of surfaces associated with animal housing by spraying
Product type |
PT03 - Veterinary hygiene (Disinfectants) |
Where relevant, an exact description of the authorised use |
Not relevant. |
Target organism(s) (including development stage) |
Common name: Bacteria Development stage: Common name: Fungi/yeasts Development stage: Common name: Viruses Development stage: |
Field(s) of use |
Indoor Disinfection of non-porous materials and surfaces associated with the housing of animals. |
Application method(s) |
Method: - Detailed description: Spraying with automated or manual equipment |
Application rate(s) and frequency |
Application Rate: Use concentration 9.5-13 % w/w hydrogen peroxide. Dilution (%): Number and timing of application: Spraying: 50 -100 mL diluted product/m2 Frequency depends on life-cycle of animals - as required by user. |
Category(ies) of users |
Professional |
Pack sizes and packaging material |
HDPE packaging: 0.25, 1, 2.5, 5, 10, 20, 22, 30, 60, 200, 220 and 1000 L (IBC). Approved grades of HDPE. |
4.2.1. Use-specific instructions for use
Dilute the product to reach the needed hydrogen peroxide concentration stated below.
Effective hydrogen peroxide concentration (w/w) and contact time:
|
Bactericidal and yeasticidal - 9.5%, 30 min |
|
Fungicidal – 13%, 60 min |
|
Virucidal – 13%, 30 min |
|
All claimed microbes - 13%, 60 min |
Each product label should give information on how the dilution should be made, e.g. to reach 13% (w/w) hydrogen peroxide concentration:
A product with 50% hydrogen peroxide concentration: The product should be diluted to 28% w/v (280 g or 230 mL of product, add water up to 1L).
Remove animals from spaces to be disinfected. Precleaning of surfaces required before using disinfectants.
Spray diluted product 50 -100 mL /m2 on non-porous surfaces. Surface needs to stay wet for the allocated contact time. Allow to drain and dry.
4.2.2. Use-specific risk mitigation measures
Automated spraying systems:
During the operation worker must leave the area and access must be denied by appropriate barriers or locked doors. After operation efficient ventilation (10 ACH) must be used to reach a safe level. During this period access must also be denied. Air concentrations must be monitored to ensure that no leakage occurs during operations. For re-entry, the undercut of AECinhalation of 1.25 mg/m3 shall be ensured with technical and organisational measures (e.g. sensor, defined ventilation period).
For manual spraying:
The use of eye protection during handling of the product is mandatory.
Wear protective chemical resistant gloves during product handling phase (glove material to be specified by the authorisation holder within the product information).
A protective coverall (at least type 6, EN 13034) shall be worn.
Use of respiratory protective equipment (RPE) providing a protection factor of 10 is mandatory. At least a powered air purifying respirator with helmet/hood/mask (TH1/TM1), or a half/full mask with combination filter gas/P2 is required (filter type (code letter, colour) to be specified by the authorisation holder within the product information).
Only operators wearing the specified RPE should be present while spraying or fumigating.
The operator must walk backward towards the exit while spraying the surfaces so always walking away from sprayed areas.
Efficient ventilation (10 ACH) must be used during spraying and access must be denied by appropriate barriers and notices, Also after operation efficient ventilation (10 ACH) must be used to reach a safe level. During this period access must also be denied. Air concentrations must be monitored to ensure that no leakage occurs during operations. For re-entry, the undercut of AECinhalation of 1.25 mg/m3 shall be ensured with technical and organisational measures (e.g. sensor, defined ventilation period).
No secondary exposure is expected because of rapid decomposition of hydrogen peroxide.
4.2.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
See general directions for use.
4.2.4. Where specific to the use, the instructions for safe disposal of the product and its packaging
See general directions for use.
4.2.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage
See general directions for use.
5. GENERAL DIRECTIONS FOR USE (9) OF THE META SPC 9
5.1. Instructions for use
-
5.2. Risk mitigation measures
The use of eye protection during handling of the product is mandatory.
Wear face shield where splashing is possible.
Ensure adequate ventilation during the application.
5.3. Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment
Particulars of likely direct or indirect adverse effects:
— |
In case of inhalation: Breathing difficulties, cough, pulmonary oedema, nausea, vomiting. |
— |
In case of skin contact: Redness, swelling of tissue, skin irritation. |
— |
In case of eye contact: Redness, lachrymation, swelling of tissue, severe burns. |
— |
In case of ingestion: Nausea, abdominal pain, bloody vomiting, diarrhoea, suffocation, cough, severe shortness of breath, severe burns of the mouth and throat, as well as a danger of perforation of the oesophagus and the stomach. Risk of respiratory disorder. |
First aid instructions:
|
IF INHALED: Move to fresh air and keep at rest in a position comfortable for breathing. If symptoms: Call 112/ambulance for medical assistance. If no symptoms: Call a POISON CENTRE or a doctor. |
|
IF ON SKIN: Immediately wash skin with plenty of water. Thereafter take off all contaminated clothing and wash it before reuse. Continue to wash the skin with water for 15 minutes. Call a POISON CENTRE or a doctor. |
|
IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing for at least 15 minutes. Call 112/ambulance for medical assistance. |
|
IF SWALLOWED: Immediately rinse mouth. Give something to drink, if exposed person is able to swallow. Do NOT induce vomiting. Call 112/ambulance for medical assistance. |
Emergency measures to protect environment in case of accident:
— |
Environmental precautions: Should not be released into the environment. If the product contaminates rivers and lakes or drains inform respective authorities. |
— |
Methods and materials for containment and cleaning up: Dilute with plenty of water. Dam up. Do not mix waste streams during collection. Soak up with inert absorbent material. Keep in properly labelled containers. Keep in suitable, closed containers for disposal. Never return spills in original containers for re-use. |
5.4. Instructions for safe disposal of the product and its packaging
Do not allow undiluted product to enter the sewer. Do not discharge unused product on the ground, into water courses, into pipes (sink, toilets…) nor down the drains.. Only pass on empty containers/packaging for recycling. Disposal of packaging should at all times comply with the waste disposal legislation and any regional local authority requirements.
5.5. Conditions of storage and shelf-life of the product under normal conditions of storage
Storage: Hydrogen peroxide should be stored in properly designed bulk storage tanks or in original vented container in upright position away from incompatible products. Use only approved materials of construction for equipment or approved packs. Store in a cool, ventilated area and protect from damage and direct sunlight. Do not store at temperatures above 40°C. Keep away from combustible materials and sources of ignition and heat.
Shelf-life: 12 months in HDPE packs at ambient temperature.
6. OTHER INFORMATION
Please be aware of the European reference value of 1.25 mg/m3 for the active substance hydrogen peroxide (CAS No.: 7722-84-1) which was used for the risk assessment for this product.
7. THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 9
7.1. Trade name(s), authorisation number and specific composition of each individual product
Trade name(s) |
INTEROX BT 50 |
Market area: EU |
||||
Authorisation number |
EU-0027468-0015 1-9 |
|||||
Common name |
IUPAC name |
Function |
CAS number |
EC number |
Content (%) |
|
Hydrogen peroxide |
|
Active Substance |
7722-84-1 |
231-765-0 |
49,9 |
(1) Instructions for use, risk mitigation measures and other directions for use under this section are valid for any authorised uses within the meta SPC 1.
(2) Instructions for use, risk mitigation measures and other directions for use under this section are valid for any authorised uses within the meta SPC 2.
(3) Instructions for use, risk mitigation measures and other directions for use under this section are valid for any authorised uses within the meta SPC 3.
(4) Instructions for use, risk mitigation measures and other directions for use under this section are valid for any authorised uses within the meta SPC 4.
(5) Instructions for use, risk mitigation measures and other directions for use under this section are valid for any authorised uses within the meta SPC 5.
(6) Instructions for use, risk mitigation measures and other directions for use under this section are valid for any authorised uses within the meta SPC 6.
(7) Instructions for use, risk mitigation measures and other directions for use under this section are valid for any authorised uses within the meta SPC 7.
(8) Instructions for use, risk mitigation measures and other directions for use under this section are valid for any authorised uses within the meta SPC 8.
(9) Instructions for use, risk mitigation measures and other directions for use under this section are valid for any authorised uses within the meta SPC 9.
19.7.2022 |
EN |
Official Journal of the European Union |
L 190/70 |
COMMISSION IMPLEMENTING REGULATION (EU) 2022/1233
of 18 July 2022
amending Implementing Regulation (EU) 2020/492 imposing definitive anti-dumping duties on imports of certain woven and/or stitched glass fibre fabrics originating in the People’s Republic of China and Egypt
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) 2016/1036 of the European Parliament and of the Council of 8 June 2016 on protection against dumped imports from countries not members of the European Union (1) (‘the basic Regulation’), and in particular Article 12 thereof,
Whereas:
1. PROCEDURE
1.1. Measures in force
(1) |
The measures currently in force are definitive anti-dumping duties imposed by Commission Implementing Regulation (EU) 2020/492 on imports of certain woven and/or stitched glass fibre fabrics originating in the People’s Republic of China and Egypt (‘the original measures’) (2). |
(2) |
The product under investigation is also subject to a definitive countervailing duty imposed by the Commission Implementing Regulation (EU) 2020/776 (3). However, the countervailing duty is not subject to this reinvestigation. |
1.2. Request for an absorption reinvestigation and initiation
(3) |
The Commission received a request for an absorption reinvestigation of the anti-dumping measures in force with respect to imports from Egypt (‘country concerned’) pursuant to Article 12 of the basic Regulation. |
(4) |
The request was lodged on 18 October 2021 by TECH-FAB Europe e.V., an association of EU producers of glass fibre fabrics (‘GFF’) (‘the applicants’), representing more than 25 % of the total Union production of GFF. |
(5) |
The applicants have submitted sufficient evidence showing that after the original investigation period, Egyptian export prices have decreased. The decrease in Egyptian export prices has seemingly impeded the intended remedial effects of the measures in force. The evidence contained in the request indicated that the decrease in export prices cannot be explained by a decrease of the price of the major raw material and other costs or by a change in the product mix. |
1.3. Reopening of the anti-dumping investigation
(6) |
On 1 December 2021, the Commission announced the reopening of the anti-dumping investigation by a notice published in the Official Journal of the European Union (‘the Notice of Reopening’) (4). |
(7) |
The reinvestigation concerned the current anti-dumping duty of 20 % imposed on Jushi Egypt For Fiberglass Industry S.A.E (‘Jushi Egypt’), Hengshi Egypt Fiberglass Fabrics S.A.E. (‘Hengshi Egypt’) (collectively referred to as ‘CNBM group’) and on ‘All other companies’ as set out in Article 1(2) of Implementing Regulation (EU) 2020/492 (5). |
1.4. Interested parties
(8) |
In the Notice of Reopening, the Commission invited interested parties to contact it in order to participate in the reinvestigation. In addition, the Commission specifically informed the applicants, exporting producers and importers known to be concerned and the authorities of the country concerned about the absorption reinvestigation and invited them to participate. |
(9) |
Interested parties were given the opportunity to make their views known in writing and to request a hearing with the Commission and/or the Hearing Officer in trade proceedings. |
1.5. Sampling of exporting producers in the country concerned to be reinvestigated
(10) |
In order to enable the Commission to decide whether sampling in accordance with Article 17 of the basic Regulation would be necessary in respect of the producers in the country concerned, those parties were requested to make themselves known and to provide the Commission with the information requested in the Notice of Reopening. In addition, the Commission requested the Mission of Egypt to the European Union to identify and/or contact other producers, if any, that could be interested in participating in the reinvestigation. However, since only Jushi Egypt and Hengshi Egypt came forward, sampling was not necessary. |
1.6. Sampling of unrelated importers
(11) |
In order to decide whether sampling was necessary and, if so, to select a sample, the Commission asked unrelated importers to provide the information specified in the Notice of Reopening. None of the unrelated importers came forward and sampling was therefore not necessary. |
1.7. Replies to the questionnaires and verifications
(12) |
The Commission sent a questionnaire to Jushi Egypt and Hengshi Egypt, to which they replied. |
(13) |
The Commission sought all the information deemed necessary for the purpose of this reinvestigation. In view of the outbreak of COVID-19, the Commission could not carry out verification visits pursuant to Article 16 of the basic Regulation at the premises of Jushi Egypt, Hengshi Egypt and trader related to Hengshi Egypt, Huajin Capital Limited in Hong Kong. The Commission therefore cross-checked remotely all the information deemed necessary of these three companies for its determinations in line with its Notice on the consequences of the COVID-19 outbreak on anti-dumping and anti-subsidy investigations (6). |
(14) |
Furthermore, verification visits pursuant to Article 16 of the basic Regulation were carried out at the premises of the following importers/traders related to Jushi Egypt/Hengshi Egypt:
|
1.8. Period covered by the absorption reinvestigation
(15) |
The absorption reinvestigation period (‘AIP’) was 1 October 2020 to 30 September 2021. The original investigation period (‘OIP’) was 1 January 2018 to 31 December 2018. |
1.9. Comments on initiation
(16) |
Following the initiation of this re-investigation the Government of Egypt (‘GoE’) submitted that a reinvestigation under Article 12 of the basic Regulation would be incompatible with the WTO anti-dumping agreement (ADA). The GoE claimed (i) that under WTO previsions no such review is provided for; (ii) that Article 12(3) of the basic Regulation would be incompatible with Article 9.1. ADA insofar as a lower duty cannot be imposed as a result of such reinvestigation and (iii) that measures imposed following a reinvestigation in accordance with Article 12 of the basic Regulation would also not fall within the exceptions granted by Article XX(d) of the GATT 1994. |
(17) |
The GoE also submitted that in contrast with the obligations under Article 11(3) of the ADA a reinvestigation in accordance with Article 12 of the basic Regulation does not require an investigation of injury. |
(18) |
The Commission noted that the fact that ADA does not explicitly provide for the possibility to review the dumping margin to take into account the absorption of anti-dumping duties does not mean that such a review would be WTO inconsistent. On the contrary, such review focuses on the dumping margin determination to ensure that the level of duties can adequately eliminate the effects of injurious dumping and is therefore warranted under Articles 11.1 and 11.2 of the ADA, and in full conformity with the applicable ADA rules including Article 2. |
(19) |
As regards the claim on Article 12(3) of the basic Regulation, it is noted that the present reinvestigation did not establish a lower dumping margin on imports of GFF from Egypt. The claim is therefore immaterial. |
(20) |
Concerning the requirement that the investigation should cover both dumping and injury, unlike reviews under Article 11(3), Article 12 is limited to reinvestigating the dumping margins only. In any event, in the present investigation the Commission did review the injury elimination level in order to fully comply with the relevant rules concerning the level of the duty. |
(21) |
The GoE also claimed that the measures in force had the intended remedial effect and that significant decrease in the volume of GFF imports between 2018 and 2020 proved the absence of absorption practices by the exporters. In its response to the final disclosure, GoE restated its argument that the Commission did not objectively examine the volume of the dumped imports and the effect of such imports on prices in the Union market for like products. First, Article 12 of the basic Regulation does not prevent the Commission from conducting absorption reinvestigation and from possibly increasing the antidumping measures in the event of decreasing imports from the country concerned. Second, changes in import volumes, as such, do not constitute or influence the absorption of anti-dumping duties in terms of changes in export prices. Third, while the imports of GFF into the Union decreased after the imposition of the anti-dumping duties, they remain sizeable and, as a matter of fact, one of the two exporting producers doubled its exports to the Union in the AIP. Hence, this claim is rejected. |
(22) |
Vestas Wind Systems A/S (‘Vestas’), a GFF user, submitted during the reinvestigation that based on its records, both the FOB price and the landed costs Vestas paid for GFF imported from Egypt to the Union have increased. In this respect, the Commission noted the following. First, the Commission’s assessment of export sales is based on collected and verified sales data provided by the exporting producers which show a decrease in export prices in the AIP as compared to the OIP. Second, the Commission’s assessment is based on totality of sales to all independent customers in the Union during the AIP and OIP respectively and is not limited to analysis of sales to individual customers. Therefore, the claim raised by Vestas is rejected. |
(23) |
Furthermore, Vestas argued that that imposing or increasing anti-dumping duties on GFF is directly contrary to the interest of the Union. It is noted that the current reinvestigation is limited to the determination whether export prices have decreased or whether there has been no movement, or insufficient movement, in resale prices or subsequent selling prices in the Union of the product under investigation since the imposition of the original measures and subsequently, if applicable to recalculate the dumping margin based on the re-assessed export prices. In accordance with Article 12 of the basic Regulation such reinvestigation does not include Union interest’s aspects. Therefore, the claim is dismissed. |
2. PRODUCT UNDER INVESTIGATION
(24) |
The product under investigation is fabrics of woven and/or stitched continuous filament glass fibre rovings and/or yarns with or without other elements, excluding products which are impregnated or pre-impregnated (pre-preg) and excluding open mesh fabric with cells with a size of more than 1,8 mm in both length and width and weighing more than 35 g/m2, originating in Egypt currently falling under CN codes ex 7019 61 00, ex 7019 62 00, ex 7019 63 00, ex 7019 64 00, ex 7019 65 00, ex 7019 66 00, ex 7019 69 10, ex 7019 69 90 and ex 7019 90 00 (TARIC codes 7019610081, 7019610083, 7019610084, 7019620081, 7019620083, 7019620084, 7019630081, 7019630083, 7019630084, 7019640081, 7019640083, 7019640084, 7019650081, 7019650083, 7019650084, 7019660081, 7019660083, 7019660084, 7019691081, 7019691083, 7019691084, 7019699081, 7019699083, 7019699084, 7019900081, 7019900083 and 7019900084) (‘the product under investigation’). |
3. FINDINGS OF THE ABSORPTION REINVESTIGATION
(25) |
The absorption reinvestigation pursuant to Article 12 of the basic Regulation aims at establishing whether or not export prices have decreased or whether there has been no movement, or insufficient movement, in resale prices or subsequent selling prices in the Union of the product under investigation since the imposition of the original measures. As a second step, if it is concluded that the measure should have led to movements in such prices, then, in order to remove the injury previously established in accordance with Article 3 of the basic Regulation, export prices shall be reassessed in accordance with Article 2 of the basic Regulation and dumping margins shall be recalculated to take account of the reassessed export prices. |
3.1. Decrease of export prices
(26) |
In this case, both exporting producers exported to the Union either directly to independent customers or through related companies and the Commission analysis focused accordingly on the evolution of export prices in the AIP as compared to the OIP. |
(27) |
When establishing whether there was a decrease in export prices, the Commission established for each examined company its cost, insurance and freight (CIF) export prices at the Union custom border during the AIP and compared these prices to the corresponding export prices determined in the OIP. |
(28) |
The Commission compared for each of the exporting producer the prices of the product types sold in the AIP with the same product types sold in the OIP and calculated for them the weighted average price difference. |
(29) |
The above comparison made for the two related exporting producers resulted in a weighted average export price decrease of 12 % for CNBM group, indicating prima facie that absorption of the measures in force was taking place. |
(30) |
Therefore, dumping margins were recalculated, according to Article 2 of the basic Regulation. |
3.2. Dumping
3.2.1. Introduction
(31) |
After having established possible absorption for CNBM group, the dumping margin was recalculated, according to Article 2 of the basic Regulation. |
(32) |
With respect to the export prices, the export prices for the AIP, collected and verified or cross-checked in the framework of this reinvestigation were used, pursuant to Article 12(2) of the basic Regulation. |
(33) |
In this case, both related exporting producers exported to the Union either directly to independent customers or through related companies, established in Hong Kong or the Union. |
(34) |
Where the exporting producers exported the product under investigation directly to independent customers in the Union, the export price was the price actually paid or payable for the product under investigation when sold for export to the Union, in accordance with Article 2(8) of the basic Regulation. |
(35) |
Where the exporting producers exported the product under investigation to the Union through a related company acting as an importer, the export price was established on the basis of the price at which the imported product was first resold to independent customers in the Union, in accordance with Article 2(9) of the basic Regulation. In that case, adjustments to the price were made for all costs incurred between importation and resale including SG&A expenses of the related importers located in the Union, and reasonable profit (established at 5 % in the original investigation). |
(36) |
Normal values as established in the original investigation are used for the calculation of dumping margins during the AIP, unless revision of the normal value taking into account changes in the AIP is requested under Article 12(5) of the basic Regulation. |
(37) |
In the present case, the exporting producers did not request a revision of the normal value. Therefore, the normal values used to recalculate the dumping margin in this case are the ones established in the original investigation. |
(38) |
For Jushi Egypt, all product types sold in the AIP were also sold in the OIP and hence all normal values were readily available. For Hengshi Egypt, two product types sold in the AIP were not sold in the OIP. Normal value for those two products was therefore replaced by the normal value for the most closely resembling product types sold by Hengshi Egypt in the original investigation. |
(39) |
Hengshi Egypt claimed in its reply to the final disclosure that for one of the product types, it is inappropriate to use the normal value from the OIP, given that such product type was only made as part of a trial production and sold in a small quantity as a sample. Instead, Hengshi Egypt suggested that the normal value from the OIP for another, allegedly nearest product type be used. |
(40) |
First, it is noted that the original investigation established that the product type in question was produced for commercial use and the normal value for the said product type was duly established and used for dumping margin calculation in the OIP. None of these determinations were contested by Hengshi Egypt in the original investigation. Second, using arbitrarily a normal value for a different product type, while the established and previously uncontested normal value for the matching product type is available would be unfounded. The statements made by the company following the final disclosure could also not be verified. The Commission therefore maintains that the normal value for the product type produced and commercially sold in the OIP (albeit in limited quantities) and corresponding to the product type sold to the Union in the AIP is the closest and most reliable proxy to be used for dumping calculations in this case. |
(41) |
In addition, although Hengshi Egypt could have requested a revision of the normal value based on Article 12(5) of the basic Regulation, if it considered that changes in normal values occurred in the AIP that merited re-examination, it did not do so. Nevertheless, while Article 12(5) of the basic Regulation allows for an en bloc revision of the normal value, it does not allow for a selective reassessment for only one or a few select product types. In light of the above, the claim raised by Hengshi Egypt has to be rejected. |
(42) |
In response to the final disclosure, Jushi Egypt disagreed to treat both Jushi Egypt as well as Hengshi Egypt jointly for the purposes of applying Article 12(5) of the basic Regulation on revision of normal values. Jushi Egypt suggests that the Commission should have accepted its individual request for reassessment of the normal value. |
(43) |
Jushi Egypt submitted that while it itself contributed to the alleged export price decrease for the whole CNBM group, Hengshi Egypt’s export prices remained at the same level as during the OIP. The decrease in Jushi Egypt’s export prices, however, would be the result of Jushi Egypt’s effort in lowering its costs in the AIP, and there would therefore be an equal effect of the decrease in costs on the normal value. In conclusion, Jushi Egypt argues that therefore its export prices were not absorbed and consequently neither the export prices of the CNBM group. Moreover, according to Jushi Egypt, the single dumping margin for the company group should have been based on the revised dumping margin for Jushi Egypt and the original dumping margin for Hengshi Egypt. |
(44) |
First, as outlined in recital (29), it is noted that an export price decrease of 12 % was established for the CNBM group comprising both Jushi Egypt and Hengshi Egypt, which led to the recalculation of dumping margins for both producing entities pursuant to Article 12(2) of the basic Regulation. |
(45) |
Second, it is recalled that the CNBM group explicitly stated that it would not seek revision of the normal value for their related exporting producers, Jushi Egypt and Hengshi Egypt. The Commission subsequently proceeded, in accordance with Article 12 of the basic Regulation, with recalculating the dumping margins based on the normal values from the OIP. |
(46) |
Third, pursuant to Article 9(5), second subparagraph of the basic Regulation, suppliers with existing structural and corporate links may be considered as a single entity for the purpose of specifying the antidumping duty. This implies that a uniform approach at the level of the group of related producers is to be adopted also in applying Article 12(5) and in conducting absorption reinvestigations. Otherwise, disparate approaches applied to individual exporting producers belonging to the same group already at preliminary stages of absorption reinvestigations could result in a distorted outcome of the reinvestigations and situations, where the exporting producers escape application of (increased) antidumping duties. It is further noted with regards to the treatment of Jushi Egypt and Hengshi Egypt as pertaining to the same corporate group that the approach taken by the Commission in this reinvestigation is fully consistent with the approach adopted in the original investigation. For the reasons set out above, Jushi Egypt’s claim has to be rejected. |
3.2.2. Comparison
(47) |
The Commission compared the normal value and the export price of the two cooperating exporting producers on an ex-works basis. |
(48) |
Where justified by the need to ensure a fair comparison, the Commission adjusted the normal value and/or the export price for differences affecting prices and price comparability, in accordance with Article 2(10) of the basic Regulation. Adjustments in this case were made for transport, insurance, handling, loading costs, credit cost and bank charges. |
(49) |
Furthermore, during the AIP, Hengshi Egypt exported GFF to the Union also through a related trader located outside the Union, in Hong Kong. Therefore, an adjustment under Article 2(10)(i) was also made for sales through that related trading company in line with the original investigation. The adjustment consisted of the deduction of SG&A of the trading company and a 5 % profit (as established in the original investigation). |
3.2.3. Dumping margin
(50) |
In order to establish the dumping margin for the two cooperating exporting producers, the Commission compared the weighted average normal value of each type of the like product with the weighted average export price of the corresponding type of the product under investigation, on an ex-works basis, in accordance with Article 2(11) and (12) of the basic Regulation. |
(51) |
As the two cooperating producers were related, a single dumping margin was established based on the weighted average of their individual dumping margins. |
(52) |
On this basis, the weighted average dumping margins expressed as a percentage of the CIF Union frontier price, duty unpaid, developed as follows:
|
3.2.4. Injury elimination level
(53) |
The Commission then determined the injury elimination level based on a comparison of the weighted average import price of CNBM group established in the AIP with the weighted average non-injurious price of the like product sold by the sampled Union producers on the Union market as established during the OIP. Any difference resulting from this comparison was expressed as a percentage of the weighted average import CIF value. |
(54) |
On that basis, the injury margin for CNBM group increased from 63,9 % to 109,3 %. |
(55) |
In response to the final disclosure. CNBM group and GoE claimed with reference to the decreasing level of imports from Egypt and the resulting decrease of CNBM market share in the Union that the anti-dumping measures in place have already well protected the Union industry, which has recovered or had opportunity to recover from the alleged material injury. Referring to a parallel anti-circumvention investigation (7) the CNBM group also claimed that selling prices of the Union producers were allegedly increasing, showing that the Union industry had recovered from the material injury suffered. CNBM group further contested the methodology used by the Commission in computing the undercutting and underselling margins, referring to their submissions in the original investigation as well as two judgments of the Court of Justice in this regard (8). Moreover, GoE submitted in response to the final disclosure that in reviewing the injury elimination margin, the Commission used a different level of trade to compare prices and thus failed to act consistently with Article 3 of the ADA on fair comparison. |
(56) |
As set out in recital (20), the present reinvestigation is limited to dumping aspects only. The injury elimination level was recalculated solely in order to fully comply with the relevant rules concerning the level of the duty and cannot affect the outcome of this reinvestigation, as the duties in both the original investigation as well as in this reinvestigation are set at the level of the dumping margin (see recital (58) for more details). Regarding to the use of information from a parallel investigation, it is to be noted that CNBM refers to a different investigation and to information that is not available on the case file in the present case. Hence even if such information were to be relevant for the purposes of this case (which is not), it could not be used in this case. In the light of the above, the CNBM group’s and GoE’s claims have to be rejected. |
4. CONCLUSION
(57) |
The dumping margin calculated for the AIP increased compared to that established in the OIP. Hence, anti-dumping measures imposed on imports of the product under investigation by the CNBM group should be amended in accordance with Article 12(3) of the basic Regulation. |
(58) |
In accordance with Article 9(4) of the basic Regulation, the amount of the duties should be set at the level of the dumping margin. In the original anti-subsidy investigation (9), the Commission did not countervail any export contingent subsidy schemes in accordance with Article 24(1) of Regulation (EU) 2016/1037 of the European Parliament and of the Council (10) (the basic Anti-subsidy Regulation) . Therefore, the countervailing duty does not need to be deducted in order to determine the new anti-dumping duty. |
(59) |
Consequently, the revised rate of anti-dumping duty applicable, before duty, to the net free-at-Union-frontier price will be as follows:
|
(60) |
In reply to the final disclosure, the applicants submitted that, because of the massive increase in undercutting, the Commission should use its full discretion and double the anti-dumping duty. |
(61) |
It is observed that the Commission acted in conformity with Article 9(4), 12(2) and 12(3) of the basic Regulation by recalculating the dumping margin to take account of the lower export prices and setting the revised antidumping duty at the level of the established dumping margin. The Commission is bound by the said provisions and contrary to the applicants’ claim does not enjoy any discretion in setting the duty beyond the level of the dumping margin in this case. Therefore, the applicants’ claim has no legal foundation and has to be dismissed. |
(62) |
On 17 May 2022, the Commission disclosed the essential facts and considerations on the basis of which it intended to impose a definitive anti-dumping duty on imports of GFF originating in Egypt. All parties were granted a period within which they could make comments on the disclosure. The comments submitted by interested parties were considered and taken into account where warranted. |
(63) |
The measures provided for in this Regulation are in accordance with the opinion of the Committee established by Article 15(1) of Regulation (EU) 2016/1036. |
HAS ADOPTED THIS REGULATION:
Article 1
In Implementing Regulation (EU) 2020/492, Article 1(1) and 1(2) shall be replaced by the following:
‘1. A definitive anti-dumping duty is imposed on imports of fabrics of woven and/or stitched continuous filament glass fibre rovings and/or yarns with or without other elements, excluding products which are impregnated or pre-impregnated (pre-preg), and excluding open mesh fabrics with cells with a size of more than 1,8 mm in both length and width and weighing more than 35 g/m 2, originating in the People’s Republic of China and Egypt, currently falling under CN codes ex 7019 61 00, ex 7019 62 00, ex 7019 63 00, ex 7019 64 00, ex 7019 65 00, ex 7019 66 00, ex 7019 69 10, ex 7019 69 90 and ex 7019 90 00 (TARIC codes 7019610081, 7019610083, 7019610084, 7019620081, 7019620083, 7019620084, 7019630081, 7019630083, 7019630084, 7019640081, 7019640083, 7019640084, 7019650081, 7019650083, 7019650084, 7019660081, 7019660083, 7019660084, 7019691081, 7019691083, 7019691084, 7019699081, 7019699083, 7019699084, 7019900081, 7019900083 and 7019900084).
2. The definitive anti-dumping duty applicable to the net, free-at-Union-frontier price, before duty, of the product described in paragraph 1 and produced by the companies listed below shall be as follows:
Country concerned |
Company |
Definitive anti-dumping duty |
TARIC additional code |
PRC |
Jushi Group Co. Ltd; Zhejiang Hengshi Fiberglass Fabrics Co. Ltd; Taishan Fiberglass Inc. |
69,0 % |
C531 |
PGTEX China Co. Ltd; Chongqing Tenways Material Corp. |
37,6 % |
C532 |
|
Other companies cooperating in both anti-subsidy and anti-dumping investigation listed in Annex I |
37,6 % |
See Annex I |
|
Other companies cooperating in anti-dumping investigation but not in anti-subsidy investigation listed in Annex II |
34,0 % |
See Annex II |
|
All other companies |
69,0 % |
C999 |
|
Egypt |
Jushi Egypt For Fiberglass Industry S.A.E; Hengshi Egypt Fiberglass Fabrics S.A.E. |
33,1 % |
C533 |
All other companies |
33,1 % |
C999’ |
Article 2
This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 18 July 2022.
For the Commission
The President
Ursula VON DER LEYEN
(1) OJ L 176, 30.6.2016, p. 21.
(2) Commission Implementing Regulation (EU) 2020/492 of 1 April 2020 imposing definitive anti-dumping duties on imports of certain woven and/or stitched glass fibre fabrics originating in the People’s Republic of China and Egypt (OJ L 108, 6.4.2020, p. 1).
(3) Commission Implementing Regulation (EU) 2020/776 of 12 June 2020 imposing definitive countervailing duties on imports of certain woven and/or stitched glass fibre fabrics originating in the People’s Republic of China and Egypt and amending Commission Implementing Regulation (EU) 2020/492 imposing definitive anti-dumping duties on imports of certain woven and/or stitched glass fibre fabrics originating in the People’s Republic of China and Egypt (OJ L 189, 15.6.2020, p. 1).
(4) Notice of reopening the anti-dumping investigation concerning imports of certain woven and/or stitched glass fibre fabrics originating in Egypt (OJ C 483, 1.12.2021, p. 29).
(5) Implementing Regulation (EU) 2020/492, amended by Implementing Regulation (EU) 2020/776.
(6) Notice on the consequences of the COVID-19 outbreak on anti-dumping and anti-subsidy investigations (OJ C 86, 16.3.2020. p. 6).
(7) See Commission Implementing Regulation (EU) 2021/2230 of 14 December 2021 initiating an investigation concerning possible circumvention of the anti-dumping measures imposed by Commission Implementing Regulation (EU) 2020/492 on imports of certain woven and/or stitched glass fibre fabrics originating in People’s Republic of China and Egypt by imports of certain woven and/or stitched glass fibre fabrics consigned from Turkey, whether declared as originating in Turkey or not, and making such imports subject to registration (OJ L 448, 15.12.2021, p. 58).
(8) Case T-242/19, Giant Electric Vehicle Kunshan v. Commission, ECLI:EU:T:2022:259, paragraph 90; Cases T-30/19 and T-72/19, CRIA and CCCMC v. Commission, ECLI:EU:T:2022:266, paragraph 153.
(9) Implementing Regulation (EU) 2020/776.
(10) Regulation (EU) 2016/1037 of the European Parliament and of the Council of 8 June 2016 on protection against subsidised imports from countries not members of the European Union (OJ L 176, 30.6.2016, p. 55).
19.7.2022 |
EN |
Official Journal of the European Union |
L 190/79 |
COMMISSION IMPLEMENTING REGULATION (EU) 2022/1234
of 18 July 2022
amending Annex I to Implementing Regulation (EU) 2021/605 laying down special control measures for African swine fever
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’) (1), and in particular Article 71(3) thereof,
Whereas:
(1) |
African swine fever is an infectious viral disease affecting kept and wild porcine animals and can have a severe impact on the concerned animal population and the profitability of farming causing disturbance to movements of consignments of those animals and products thereof within the Union and exports to third countries. |
(2) |
Commission Implementing Regulation (EU) 2021/605 (2) was adopted within the framework of Regulation (EU) 2016/429, and it lays down special disease control measures regarding African swine fever to be applied for a limited period of time by the Member States listed in Annex I thereto (the Member States concerned), in restricted zones I, II and III listed in that Annex. |
(3) |
The areas listed as restricted zones I, II and III in Annex I to Implementing Regulation (EU) 2021/605 are based on the epidemiological situation of African swine fever in the Union. Annex I to Implementing Regulation (EU) 2021/605 was last amended by Commission Implementing Regulation (EU) 2022/1196 (3) following changes in the epidemiological situation as regards that disease in Germany and Poland. |
(4) |
Any amendments to restricted zones I, II and III in Annex I to Implementing Regulation (EU) 2021/605 should be based on the epidemiological situation as regards African swine fever in the areas affected by that disease and the overall epidemiological situation of African swine fever in the Member State concerned, the level of risk for the further spread of that disease, as well as scientifically based principles and criteria for geographically defining zoning due to African swine fever and the Union’s guidelines agreed with the Member States at the Standing Committee on Plants, Animals, Food and Feed and publicly available on the Commission’s website (4). Such amendments should also take account of international standards, such as the Terrestrial Animal Health Code (5) of the World Organisation for Animal Health and justifications for zoning provided by the competent authorities of the Member States concerned. |
(5) |
There have been new outbreaks of African swine fever in kept porcine animals in Latvia and Lithuania. |
(6) |
In July 2022, several outbreaks of African swine fever in kept porcine animals were observed in the Kuldigas and Ventspils counties in Latvia in areas currently listed as restricted zones II in Annex I to Implementing Regulation (EU) 2021/605. Those new outbreaks of African swine fever in kept porcine animals constitute an increased level of risk, which should be reflected in that Annex. Accordingly, those areas of Latvia currently listed as restricted zones II in that Annex, should now be listed as restricted zones III in that Annex instead of as restricted zones II thereof and the current boundaries of restricted zones II also need to be redefined to take account of those recent outbreaks. |
(7) |
Also, in July 2022, one outbreak of African swine fever in kept porcine animals was observed in the Marijampoles county in Lithuania in an area currently listed as restricted zone II in Annex I to Implementing Regulation (EU) 2021/605. This new outbreak of African swine fever in kept porcine animals constitutes an increased level of risk, which should be reflected in that Annex. Accordingly, this area of Lithuania currently listed as restricted zone II in that Annex, should now be listed as restricted zone III in that Annex instead of as restricted zone II thereof and the current boundaries of restricted zone II also need to be redefined to take account of this recent outbreak. |
(8) |
Following those recent outbreaks of African swine fever in kept porcine animals in Latvia and Lithuania and taking into account the current epidemiological situation as regards African swine fever in the Union, zoning in those Member States has been reassessed and updated. In addition, the risk management measures in place have also been reassessed and updated. These changes should be reflected in Annex I to Implementing Regulation (EU) 2021/605. |
(9) |
In order to take account of the recent developments in the epidemiological situation of African swine fever in the Union, and in order to combat the risks associated with the spread of that disease in a proactive manner, new restricted zones of a sufficient size should be demarcated for Latvia and Lithuania and duly listed as restricted zones II and III in Annex I to Implementing Regulation (EU) 2021/605. As the situation as regards African swine fever is very dynamic in the Union, when demarcating those new restricted zones, account has been taken of the situation in the surrounding areas. |
(10) |
Given the urgency of the epidemiological situation in the Union as regards the spread of African swine fever, it is important that the amendments to be made to Annex I to Implementing Regulation (EU) 2021/605 by this Implementing Regulation take effect as soon as possible. |
(11) |
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed, |
HAS ADOPTED THIS REGULATION:
Article 1
Annex I to Implementing Regulation (EU) 2021/605 is replaced by the text set out in the Annex to this Regulation.
Article 2
This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 18 July 2022.
For the Commission
The President
Ursula VON DER LEYEN
(2) Commission Implementing Regulation (EU) 2021/605 of 7 April 2021 laying down special control measures for African swine fever (OJ L 129, 15.4.2021, p. 1).
(3) Commission Implementing Regulation (EU) 2022/1196 of 11 July 2022 amending Annex I to Implementing Regulation (EU) 2021/605 laying down special control measures for African swine fever (OJ L 185, 12.7.2022, p. 77).
(4) Working Document SANTE/7112/2015/Rev. 3 “Principles and criteria for geographically defining ASF regionalisation”. https://ec.europa.eu/food/animals/animal-diseases/control-measures/asf_en
(5) OIE Terrestrial Animal Health Code, 29th Edition, 2021. Volumes I and II ISBN 978-92-95115-40-8; https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/
ANNEX
Annex I to Implementing Regulation (EU) 2021/605 is replaced by the following:
‘ANNEX I
RESTRICTED ZONES
PART I
1. Germany
The following restricted zones I in Germany:
Bundesland Brandenburg:
|
Bundesland Sachsen:
|
Bundesland Mecklenburg-Vorpommern:
|
2. Estonia
The following restricted zones I in Estonia:
— |
Hiiu maakond. |
3. Greece
The following restricted zones I in Greece:
— |
in the regional unit of Drama:
|
— |
in the regional unit of Xanthi:
|
— |
in the regional unit of Rodopi:
|
— |
in the regional unit of Evros:
|
— |
in the regional unit of Serres:
|
4. Latvia
The following restricted zones I in Latvia:
— |
Dienvidkurzemes novada, Grobiņas pagasts, Nīcas pagasta daļa uz ziemeļiem no apdzīvotas vietas Bernāti, autoceļa V1232, A11, V1222, Bārtas upes, Otaņķu pagasts, Grobiņas pilsēta, |
— |
Ropažu novada Stopiņu pagasta daļa, kas atrodas uz rietumiem no autoceļa V36, P4 un P5, Acones ielas, Dauguļupes ielas un Dauguļupītes. |
5. Lithuania
The following restricted zones I in Lithuania:
— |
Kalvarijos savivaldybė, |
— |
Klaipėdos rajono savivaldybė: Agluonėnų, Dovilų, Gargždų, Priekulės, Vėžaičių, Kretingalės ir Dauparų-Kvietinių seniūnijos, |
— |
Marijampolės savivaldybė, |
— |
Palangos miesto savivaldybė, |
— |
Vilkaviškio rajono savivaldybė. |
6. Hungary
The following restricted zones I in Hungary:
— |
Békés megye 950950, 950960, 950970, 951950, 952050, 952750, 952850, 952950, 953050, 953150, 953650, 953660, 953750, 953850, 953960, 954250, 954260, 954350, 954450, 954550, 954650, 954750, 954850, 954860, 954950, 955050, 955150, 955250, 955260, 955270, 955350, 955450, 955510, 955650, 955750, 955760, 955850, 955950, 956050, 956060, 956150 és 956160 kódszámú vadgazdálkodási egységeinek teljes területe, |
— |
Bács-Kiskun megye 600150, 600850, 601550, 601650, 601660, 601750, 601850, 601950, 602050, 603250, 603750 és 603850 kódszámú vadgazdálkodási egységeinek teljes területe, |
— |
Budapest 1 kódszámú, vadgazdálkodási tevékenységre nem alkalmas területe, |
— |
Csongrád-Csanád megye 800150, 800160, 800250, 802220, 802260, 802310 és 802450 kódszámú vadgazdálkodási egységeinek teljes területe, |
— |
Fejér megye 400150, 400250, 400351, 400352, 400450, 400550, 401150, 401250, 401350, 402050, 402350, 402360, 402850, 402950, 403050, 403450, 403550, 403650, 403750, 403950, 403960, 403970, 404650, 404750, 404850, 404950, 404960, 405050, 405750, 405850, 405950, |
— |
406050, 406150, 406550, 406650 és 406750 kódszámú vadgazdálkodási egységeinek teljes területe, |
— |
Győr-Moson-Sopron megye 100550, 100650, 100950, 101050, 101350, 101450, 101550, 101560 és 102150 kódszámú vadgazdálkodási egységeinek teljes területe, |
— |
Jász-Nagykun-Szolnok megye 750150, 750160, 750260, 750350, 750450, 750460, 754450, 754550, 754560, 754570, 754650, 754750, 754950, 755050, 755150, 755250, 755350 és 755450 kódszámú vadgazdálkodási egységeinek teljes területe, |
— |
Komárom-Esztergom megye 250150, 250250, 250450, 250460, 250550, 250650, 250750, 251050, 251150, 251250, 251350, 251360, 251650, 251750, 251850, 252250, kódszámú vadgazdálkodási egységeinek teljes területe, |
— |
Pest megye 571550, 572150, 572250, 572350, 572550, 572650, 572750, 572850, 572950, 573150, 573250, 573260, 573350, 573360, 573450, 573850, 573950, 573960, 574050, 574150, 574350, 574360, 574550, 574650, 574750, 574850, 574860, 574950, 575050, 575150, 575250, 575350, 575550, 575650, 575750, 575850, 575950, 576050, 576150, 576250, 576350, 576450, 576650, 576750, 576850, 576950, 577050, 577150, 577350, 577450, 577650, 577850, 577950, 578050, 578150, 578250, 578350, 578360, 578450, 578550, 578560, 578650, 578850, 578950, 579050, 579150, 579250, 579350, 579450, 579460, 579550, 579650, 579750, 580250 és 580450 kódszámú vadgazdálkodási egységeinek teljes területe. |
7. Poland
The following restricted zones I in Poland:
w województwie kujawsko - pomorskim:
|
w województwie warmińsko-mazurskim:
|
w województwie podlaskim:
|
w województwie mazowieckim:
|
w województwie podkarpackim:
|
w województwie świętokrzyskim:
|
w województwie łódzkim:
|
w województwie śląskim:
|
w województwie pomorskim:
|
w województwie lubuskim:
|
w województwie dolnośląskim:
|
w województwie wielkopolskim:
|
w województwie opolskim:
|
w województwie zachodniopomorskim:
|
w województwie małopolskim:
|